









The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 











Identification of the Virulence Gene 
of Mycobacterium tuberculosis 
By 
Halimah Adenike Rabiu 
B.Sc. (Hons) Applied Biotechnology 
University of the Western Cape 
Thesis presented for the Degree of Masters of Science (Bioinformatics) 
in the Department of Cell and Molecular Biology 











Identification of the Virulence Gene 
of Mycobacterium tuberculosis 
H ,uimah Adt nike Rabill 












The number of human deaths as a result of infections from microbial pathogens is 
enormous and is on the increase. Despite advance in drug design methods and effective 
drug and vaccine administration against major infectious diseases, infections due to 
microbes still constitute the major cause of death and disability worldwide. 
Mycobacterium tuberculosis, the causative agent of tuberculosis is the major cause of 
human death from a single infectious agent among adults in developing countries. It kills 
over 3 million people annually with the number on the increase due to the outbreak of 
multi-drug resistance strain in various places. In Sub-Sahara Africa as a consequence of 
the HIV-AIDS pandemic, the incidence of tuberculosis has worsened. In South Africa 
alone, roughly 1000 people die of the disease each day. This is even becoming more 
worrisome with the emerging threat of mutant strains of these pathogens that are 
resistant to available antibiotics and vaccines. 
However, the emergence of complete genome sequences for various microbial 
pathogens means all potential targets are catalogued. One of the main goals of microbial 
comparative genomics using bioinformatics tools is to narrow down the search for genes 
that are essential for pathogen survival in their host and provide, opportunities for 
understanding and combating infectious diseases in human. Microbes have the uncanny 
ability to adapt to their environment, which results in ever changing targets for drug and 
vaccine research and making their control and eradication extremely difficult. We believe 
that genes that are unique to the pathogens should be a priority for future studies. The 
availability of the sequence data has enormous potential, but more relevant is the 
mechanisms involved in virulence, infection and disease progression. 
The major thrust of this project is to identify and characterize potential virulence genes 
from M. tuberculosis. To this end, we have compiled and integrated information from 
various public databases to catalogue 246573 microbial genes from 84 organisms, 
including pathogens and non pathogenic microbes. We determined the phylogenetic 
distributions by grouping the proteins into families based on sequence similarity with the 
aid of BLASTP and the NCBI BLASTClust program. Three sets of experiments were 
generated with the two approaches and the results exported into binary and gene 
number matrices. Potential virulence genes were predicted to be those unique to 











8459 and 7904 proteins clusters that are unique to pathogens from the three 
experiments BLASTClust1.0, BLASTP, and BLASTClustO.5, respectively, with the most 
constrained experiment producing the largest number of pathogen specific clusters. This 
experiment, BLASTClust1.0, produced 2362 pathogen-specific clusters that included a 
member from M. tuberculosis. 
We then performed functional analyses of these potential virulence genes and predicted 
potential functions for some hypothetical proteins using InterPro and gene ontology 
annotations. Further evolutionary analysis was also performed to confirm that protein 
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" ..... .. It may be expected that the elucidation of the aetiology of tuberculosis will 
provide new viewpoints for the study of other infectious diseases." 
- Robert Koch, 1882 
1.1 General Overview 
Pathogens are microscopic organisms and include bacteria, viruses, fungi or parasites 
that infect other organisms using the host body to live and grow, and often affect normal 
cellular functions, leading to illness in the host. Human death annually as a result of 
infections from microbial pathogens is enormous and is on the increase. A significant 
advancement has been recorded in drug design methods and effective drug and vaccine 
administration against major infectious diseases. However, infections and diseases due 
to microbial pathogens are still the leading cause of death and disability worldwide. 
The world is witnessing the emergence of new infectious diseases and re-emergence of 
old deadly ones [Smolinsk et al., 2003; Cooksey, 1996; Pablos-Mendez, 1998]. Mutant 
strains of the virulent genes of the pathogens that are resistant to available antibiotics 
and vaccines are becoming more prevalent [Spratt, 1996; Bottger et al., 1998]. The 
uncanny adaptability of these pathogenic mutant strains is greatly threatening public 
health and well-being. This necessitates a significant improvement in our ability to detect, 
control and eliminate these disease-causing microbes [Nair et al., 1993; Riska et al., 
1999]. Mycobacterium tuberculosis, the causative agent for Tuberculosis (TB), for 
instance, kills over 3 million people annually [WHO, 1998; Murray and Nardell, 2002]. It 
is estimated by the World Health Organisation [2002] that one third of the world's 










2 Chapter 1: Introduction 
incidence rate (number of new cases) of 356 per 100,000 in Africa. About 8.9 million new 
cases of active TB were diagnosed worldwide in 2006 [WHO, 2006] and these figures 
probably represent less than half the true number of new cases. In South Africa alone, 
roughly 1000 people die of the disease each day [WHO, 1998] probably due to HIV 
infection complications. Ironically, TB is a theoretically preventable as well as a curable 
disease, yet it is far from being a disease of the past. With the AIDS pandemic, the 
incidence of tuberculosis has increased further, leading to the WHO declaring 
tuberculosis a global emergency in 1993 [WHO, 1998]. 
Tuberculosis is caused by the invasion of the macrophage by an intracellular pathogen 
Mycobacterium tuberculosis [Dietrich et al., 2006; Glickman and Jacobs, 2001; 
Raviglione et al., 1995], an organism that has evolved a complicated and advanced 
survival and evasion mechanism [Dietrich et al., 2006]. It is known that M. tuberculosis 
has survived inside even fully activated macrophages [Baumann et al., 2006]. TB is one 
of the ancient infectious diseases that are still endemic in the human population today. 
The oldest evidence of TB was obtained in Egyptian mummies dated about 24000 BC 
[Heifets and Good, 1994]. Despite being a very old disease, little is still known about how 
to eradicate this and related diseases. TB still maintains the reputation of being the major 
cause of human death from a single infectious agent among adults in developing 
countries [Dietrich et al., 2006; WHO, 1998; Dolin and Kochi, 1994]. 
Coupled with the HIV-AIDS pandemic in developing countries (sub-Saharan Africa in 
particular) the disease is fast becoming one of the most deadly of the major AIDS-
related opportunistic infections [Edlin et al., 1992]. While many of the common microbial 
pathogens can be prevented by vaccines or cured by antibiotics, slow diagnosis of the 
causative agents in patients and the emergence of multi drug-resistant strains of M. 
tuberculosis is a major impediment to eradication of TB [Dietrich et al., 2006; Kim, 2005]. 
The understanding of the infection mechanisms of microbial pathogens requires the 
understanding not only of the biology of the pathogens concerned, but equally important 
is the whole range of the cellular and immune responses these microbes stimulate in the 
host organism [Lara-Tejero et al., 2006]. 
Microbial pathogenesis investigates the mechanisms by which microbes cause diseases 
in their host by probing the molecular interactions between specific microbial products 
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that are used by microbes to evade the host defense mechanisms through targeting and 
modification of host cellular processes. This is achieved for instance by expression of 
genes that produce toxins, adhesions, capsules, and other molecules involved in the 
invasion of host cells and tissues, ensuring the microbe's survival but resulting in disease 
(and even death) in the host [Fruth and Young, 2004]. 
Microbes have the uncanny ability to adapt to their environment, which results in ever 
changing targets for drug and vaccine research, making their control and eradication 
extremely difficult [Sambandamurthy and Jacobs, 2005]. A detailed elaboration of the 
microbial pathogenicity pathways and strategies on a molecular level will enable the 
rapid development of effective drugs, antimicrobials, vaccines and diagnostic tools to 
combat the menace [Glickman and Jacobs, 2001; Weinstock et al., 2000]. This is only 
recently feasible in the case of M. tuberculosis with the successful efforts to genetically 
manipulate the organism [Cole et al., 1998; Bardarov, et al., 1997; Pelicic et al., 1997]. 
Towards this end, the emergence of complete genome sequences for microbial 
pathogens provides a database of the potential targets for customised drugs and 
vaccines [Weinstock et al., 2000]. 
The availability of the sequence data has enormous potential, but for practical 
applications, a comprehensive elucidation of the mechanisms involved in virulence, 
infection and disease progression are essential too [Lonnroth et al., 1999]. Recent 
advances in comparative and functional genomic studies have provided researchers with 
a valuable understanding of the biological functions of genes [pelicic et al., 1997] and 
hence made available vital information to rapidly zero in on potential drug and vaccine 
candidate genes [Lowrie, 2006]. Availability of genomic sequence has moved the focus 
of understanding the biology of an organism from the single gene to the whole genome, 
which provides the opportunity to look at genes within their context in a cell and achieve 
a global view [Scarselli et al., 2005]. 
1.2 Potential of Bioinformatics Tools 
Bioinformatics can literarily be summed up as the synergy of Information Science, 
Statistics (and to some degree Mathematics) and Applied Biology [Luscombe et al., 
2001]. It basically involves the storage, organization and indexing of sequence 
information on one hand, and the analysis of this information on the other [Becker, 2005]. 
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fundamental biological functions of organisms. This information can be employed, 
among other things, in the development of drugs, antibiotics, biological systems and 
vaccines to combat the menace of microbes [Schultz et al., 2002]. It can also find 
application in a plethora of other processes, viz environmental, agricultural and medical 
research. 
The big challenge in bioinformatics is to provide the means and tools for efficient storage 
and management of the huge volume of genomic data being produced, and making it 
easily accessible to the public [Blanchard, 2004]. Analyzing a whole genome using 
bioinformatics tools provides insights into the potential functions of genes and hence 
greatly reduces the number of experiments needed to be carried out to confirm the 
function [Brosch et al., 2000]. With the advent of a variety of bioinformatics tools, 
analysis of genomic sequence data has been made easier by reducing the number of 
genes of interest for follow-up studies with respect to a particular problem [van den 
Braak et a/., 2004]. 
The availability of genome sequences of diverse organisms provides a catalogue that 
can easily be accessed for any potential drug targets or vaccine candidates, since, for 
microbial genomes, the potential genes have been predicted [van den Braak et a/., 
2004]. The difficulty lies in identifying which genes are the targets or candidates, a task 
that requires filtering the genomiC data by some means and elucidation of the function of 
relevant gene products [Lowrie, 2006]. 
There is a tripod of fundamental theories upon which the study of bioinformatics revolves 
(http://www.ebLac.ukl2can/bioinformatics/bioinCwhy_1.html): 
• DNA sequence determines protein sequence 
• Protein sequence determines protein structure 
• Protein structure determines protein function. 
A detailed elucidation of the biological pathways of each of these processes will enable a 
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1.3 Problem being addressed 
The amount of genomic data from sequencing projects has grown exponentially over the 
last few years due to the introduction of new and faster sequencing technologies. 
Currently over 400 published complete genomes are available on the Genome On Line 
Database (GOLD) and more than a thousand are in the pipeline at about 10 major 
sequencing centres [Liolios et al., 2006]. 
The effort to include genomes of different strains of the same species in the sequencing 
projects provides the opportunity for both intra-species genomic comparisons and 
comparisons between genomes of related species. Significant successes have been 
recorded in comparative and functional genomics studies performed on mycobacterial 
species. These efforts seek to understand the evolution of these pathogens [Brosch et 
al., 2001; Cole et al., 1998] and how they interact with their various hosts. This is 
achieved by techniques of proteomics, transcriptomics and microarray analysis, among 
others. 
Of particular relevance to this work are the successful efforts of previous researchers to 
catalogue whole genome sequences of many members of the Mycobacterial species 
[Fleischmann et al., 2002]. Researchers have compared the sequences with other 
bacterial species [Gordon et al., 1999; T0njum et al., 1998] and with the genome 
sequences of other organisms, including other microbes, pathogens, mice and men 
[Poux et al., 2002]. This is to enhance specificity in identification of essential genes, by 
pinpointing potentially unique proteins. The comparative studies and other molecular 
techniques revealed the diversity and complexity within the genus. For instance, the 
analysis of isolates from environmental and clinical sources suggests that the prevailing 
theories of the origin of tuberculosis coinciding with the domestication of cattle are 
unlikely to be correct [Fleischmann et al., 2002]. Significant deletions were observed 
when the M. tuberculosis genome was compared with that of M. bovis. 
Many comparative genomics studies have been performed for identification of unique 
proteins between pathogens [Prentice, 2004; Gil et al., 2004], non-pathogens, 
[Nascimento et al., 2004] different species of the same genus [Nascimento et al., 2004; 
Ferretti et al., 2004; Moreira et al., 2004] or between different strains of a species [Deng, 
2003; Siew, 2004]. Identification of unique proteins at different taxonomic levels has 
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different organisms. Some have been successful in identifying potential virulence factors, 
but few have proceeded to further characterise these factors. In addition, each study 
has, in general, used a single reference genome to determine the difference 
between organisms. 
This project involves more detailed comparative genomics studies to produce a 
comprehensive microbial gene resource. The resource was used to identify genes that 
are unique to pathogens and genes unique to M. tuberculosis, and thus the genes 
potentially involved in virulence. However, it has also shed light on similarities and 
differences between other organisms, and not just the reference one. The work has 
also included a downstream analysis of candidate genes and proteins as opposed to the 
majority of comparative genomics studies that focussed more on the genome 
comparisons and only hinted at potential functions of interesting genes. 
The current trends in bioinformatics studies often place major and disproportionate focus 
on statistics and computational techniques. Here the aim is to employ bioinformatics 
tools to elaborate on the biological functions and pathways to try to understand the 
process and evolution of virulence in microbial pathogens rather than the traditional 
large-scale computational biology approach. At the same time, a comprehensive 
catalogue of microbial genes and their phylogenetic distributions has been created. 
1.4 General Objectives 
This project focuses on using various Bioinformatics resources to compare genomes of 
pathogens and non-pathogenic bacteria using functional and comparative genomics. It is 
aimed at identifying and characterizing virulence genes from Mycobacterium 
tuberculosis. 
Characterization of these specific genes will help to gain insight into their mode of 
pathogenicity and virulence, and subsequently aid in the identification of candidate 
vaccines and drug targets. A better understanding of the organism's mechanisms of 
infection and survival in the host will enable subsequent studies to investigate creating 
more selective and faster diagnostic reagents for tuberculosis and eventually eliminate 
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1.4.1 Specific Objectives 
This study aimed to produce a catalogue of all microbial genes and determine their 
phylogenetic profiles. This was employed further for identifying homologous genes 
between 84 completely sequenced bacterial genomes and cataloguing the genes into 
pathogen and non-pathogen sets with the aid of a binary matrix. The genes that are 
common to pathogens were then characterized, paying specific attention to genes that 
are unique to M. tuberculosis strain CDC1551. 
The approach involves comparative genomics and proteomics, data mining and storage 
of the results in a gene matrix. It has produced a comprehensive microbial gene 
catalogue that was used to answer the following questions: 
1) What is the phylogenetic profile of all microbial genes? 
2) What genes are common to all pathogens and absent from non-pathogens, and 
which genes are unique to M. tuberculosis? 
3) What genes are potentially involved in virulence in M. tuberculosis? 
4) What is the potential role of these genes in virulence? 
5) How did these genes evolved? 
1.5 General Approach 
The project was carried out using whole proteome comparisons to produce sets of 
potential homologous groups using BLASTP [Altschul et al., 1990], NCBI BLASTClust 
[http://biowulf.nih.gov/apps/blastJdoc/blastciust.html] and the InterPro database [Mulder 
et al., 2005]. Basic alignment search tool (BLAST) is a statistical algorithm used to find 
regions of similarity between two or more sequences. The aligned regions, referred to as 
segment pairs, usually consist of gapless alignments of any part of two sequences: the 
query sequence and the database. The sum of the scoring matrix values within the 
alignment regions is higher than the level that could be expected to occur by chance 
alone. 
The NCBI BLASTClust program program clusters protein sequences into sets of related 
proteins based on sequence similarity, E-value, percentage sequence identity or score 
density and percentage overlap between sequences. InterPro is a database that 
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assembles information from various protein signature databases that are generated 
through different protein signature methods. InterPro provides information on the families 
a protein belongs to and the functional domains it contains [Mulder et al., 2005; Apweiler 
et al., 2001]. 
Sequence similarity searches were carried out using BLASTP [Altschul et al., 1990] 
followed by clustering proteins into related sets based on E-value and percentage 
overlap between two sequences with the aid of PYTHON scripts, and the NCBI 
BLASTClust program [http://biowulf.nih.gov/apps/blast/doc/blastclust.html]. Three sets of 
experiments were generated with the two approaches and exported into phylogenetic 
profiles by putting representative gene names/homologue set names down the first 
column and organism names across the first row of the matrices. The rest of the matrices 
were populated with the corresponding accession numbers. 
Futher functional analyses were then carried out using various annotation data like 
UniProt description, GO slim terms and InterPro names for each experimental set. 
Evolutionary analyses of selected homologue sets (those that include candidate 
virulence genes from Mycobacterium tuberculosis) were also carried out. Figure 1 
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2.1 History of Tuberculosis 
2 
Survey of the Literature 
"If the opportunity to end tuberculosis is not 
seized now, it may be lost indefinitely" 
Human death as a result of TB infection has been long recorded [Bates and Stead, 
1993]. Hard bones that were deformed by TB have been identified thousands of years 
later, the oldest of which were found in various fragments of Egyptian mummies from 
2400 Be [Daniel, 2006; Gradmann, 2006]. Similar discoveries were found in Europe and 
the Middle East, suggesting that TB is an ancient, world wide disease [Haas and Haas, 
1996; Smith, 2003]. There are various records of the disease in ancient works of Greek 
physicians (prominent among whom is Hippocrates) and Hebrews (Schachepheth in 
Modern Hebrew translates to tuberculosis). The disease, due to its widespread nature, 
was variously referred to as white plague, white swelling, phthisis, Lupus vulgaris (TB of 
the skin), Scrofula (lymph glands TB), Mesenteric disease (TB of the abdominal lymph 
glands), Pott's disease (TB of the spine), consumption and so on [Murray, 2004]. 
The infectious nature of TB was first described in the early 18th century by the English 
physician, Benjamin Marten [Sarrel, 2006]. He postulated that TB is caused by microbes-
wonderfully minute living creatures- and is transmitted to a healthy person via frequent 
long time contact and interactions with a consumptive patient. He rightly opined then that 
short time contact with consumptive patients is seldom, or never, sufficient to transmit 
the disease. This is a landmark conceptual departure from the earlier belief that the 
disease just appears spontaneously in its victim and is incurable. 
Marten's work was supported by the discovery of Jean-Antoine Villemin, a French doctor 
in 1865, that consumption could be passed from humans to cattle and from cattle to 
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the disease is caused by a specific micro organism and did not arise spontaneously in its 
sufferers, and marks the beginning of the actual fight against the organism that causes 
TB. This first attempt was the creation of sanatoria to isolate the infected people and 
hence prevent the spread of the disease and at the same time provide a healthy rest 
house to aid the healing process [Trudeau, 1887 cited by Murray, 2004]. 
A new dawn towards a pathological understanding of the disease was witnessed with the 
isolation and description of the causative microbes for tuberculosis in March 1882 by a 
German bacteriologist named Robert Koch as tuberculosis bacteria or tubercle bacilli 
[Gradmann, 2001; Gradmann, 2006]. He developed a special staining technique that 
allowed him to view the organism [Krause, 1932 as cited by Murray, 2004]. The work 
earned him the Nobel Prize for physiology or medicine in 1905 [Murray, 2004]. He 
announced tuberculin, a glycerine extract of the tubercle bacilli, as a remedy for 
tuberculosis in 1890. This medication, though it proved ineffective, formed the basis of 
the efforts of Von Pirquet the search for a cure for pre-symptomatic tuberculosis [Sakula, 
1982]. 
The discovery by Forlanini, an Italian physician that lung collapse had a positive effect on 
the outcome of the disease marked the beginning of active therapy for TB [Doetsch, 
1978]. He developed and introduced surgical methods and artificial pneumothorax to 
reduce lung volume to combat the disease [Skeiky and Sadoff, 2006]. Wilhelm Konrad 
von Rontgen introduced radiation that could be used to view the progress and severity of 
the disease in a patient in 1895. 
Although a number of other treatments were tried to combat the menace of this 
seemingly unstoppable disease, the first success in immunizing against tuberculosis was 
named after the two French biologists that discovered it, Albert Calmette and Camille 
Guerin, in 1906 [Gradmann, 2006]. The BCG vaccine, developed from an attenuated 
bovine-strain tuberculosis, was first used on humans on the 18th July 1921 in France 
[Daniel, 2000] and later adopted throughout the world. It is still in use today as 
prevention for TB. 
Selman Waksman and his team at the University of California successfully isolated an 
effective antibiotic, actinomycin. This, however, was found to be too toxic for use in 
humans or animals [Murray, 2004]. The team eventually succeeded in 1943 to produce a 
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out to be effective against Mycobacterium tuberculosis, and non-toxic to humans. It was 
first administered to a human in November 1944, halting sensationally the progression of 
the disease [Daniel, 2000]. 
With time, more effective TB drugs and vaccines were developed - para-aminosalisylic 
acid, PAS (in 1946); Isoniazid, INH (1951); Pyrazinamide (in 1954); Cycloserine (1955); 
Ethambutol (1962); Rifampicin (1963) and so on, to combat TB [Global Tuberculosis 
Institute, http://www.umdnj.edu/ntbcweb/tbhistorv.html This was very important in light of 
the fact that antibiotic resistant mutants quickly began to appear. For instance, as early 
as 1947, resistance to streptomycin has been recorded [Ryan, 1992]. 
2.2 Modes of Infection, Transmission and Clinical Manifestations 
Tuberculosis is a disease caused by a slow growing aerobic bacterium, Mycobacterium 
tuberculosis (MTB). The microbe is one of the most successful bacterial pathogens in the 
history of mankind in terms of its persistent uncanny adaptability to survive and thrive. A 
wide variety of anti-TB drugs have been developed yet the pathogen is still the leading 
cause of human death from infectious diseases [Burgos and Pym, 2002]. M. tuberculosis 
is a pathogen that can live for years in its host, in latent states, without manifesting any 
symptoms. It was found that the risk of latent TB progressing to active tuberculosis is 
highest during the first 2 years of infection [Ferebee, 1978 cited by Elad et al., 2001]. 
While only 10% of TB infection progresses to TB disease, if untreated the diseases 
eventually causes chronic debilitation and death [Frieden and Munsiff, 2005]. 
The disease commonly manifests as pulmonary TB that affects the lungs, but infection 
can spread via blood from the lungs to all organs in the body, like bones and joints, 
central nervous system, and genital and urinary organs [Doetsch, 1978]. However, only 
the pulmonary form of the disease (or in the lung) is infectious, TB in other parts of the 
body, such as the kidney or spine, is usually not infectious. 
TB is spread almost exclusively by airborne transmission [Blower et al., 1995]. It is 
transmitted from person to person through the inhalation of the bacteria released into the 
air when a person with pulmonary or laryngeal TB coughs, sneezes or speaks. Infection 
occurs via inhalation of aerosols or air containing droplet nuclei of the bacilli [Frieden and 
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for several hours. There is as yet no agreement about the safe exposure time to airborne 
Mycobacterium tuberculosis [Sudre et al., 1992]. The bacteria usually settle in the lungs, 
begin to grow and then invade other parts of the body, such as the kidney, spine and 
brain. As mentioned previously, while TB of the lungs (pulmonary TB) or throat 
(Laryngeal TB) can be spread to other people, TB in other parts of the body, such as the 
kidney or spine, is usually not infectious [Blower et al., 1996]. Ussery et al., [1995] and 
Hutton et al., [1990] have, however, reported cases of extra-pulmonary TB transmission. 
The probability that TB will be transmitted depends on various factors like the number of 
organisms expelled into the air, duration of exposure, and the virulence of the bacterial 
strain [Sterling et al., 2006]. The tuberculosis bacteria are killed when exposed to 
ultraviolet light, including sunlight. The organism's infection pathogenesis occurs in two 
stages: the first stage is regarded as latent TB (or TB infection) where the infected 
organism remains in a dormant (albeit alive) state and this state may persist for many 
years and sometimes for the entire life time of the host. During this state, the host show 
no sign of the disease and cannot transmit it. 
The progression from latent TB to the active TB (TB disease) stage is triggered by a 
weakening in the immunological defence system of the host, allowing the bacteria to 
multiply. This may be as a result of many factors, including incidence of infections that 
compromise the immune system like HIV [Murray and Salomon, 1998; Shafer and Edlin, 
1996; Selwyn et al., 1989] and Diabetes [Rieder, 1989, COCP, 1992]. Other factors that 
may cause the progression of TB are the infective burden of Mycobacterium 
tuberculosis, previous exposure to TB infection, virulence of the Mycobacterium 
tuberculosis strain and a host of other factors. 
Selwyn et al. [1989] and Selwyn et al. [1992] reported that the risk of developing TB is 
7% to 10% each year for persons who are infected with both M. tuberculosis and HIV. 
The risk is about 10% over a lifetime for persons infected only with M. tuberculosis. Also, 
while the global TB fatality rate is 23%, the value exceeded 50% in some African 
countries with high HIV rates [Dye et al., 1999]. The major occurrence of active TB is in 
the form of Pulmonary TB -about 73% [COCP, 1999]. This form is characterized by 
chronic or persistent cough and sputum production, fatigue, lack of appetite, weight loss, 
fever, and night sweats [COCP, 1999]. If left untreated, this may be followed by coughing 










14 Chapter 2: Survey of Literature 
lymphadenopathy in Lymphadenitis TB, acute illness with cough, pleuritic chest pain, 
fever, or dyspnea in Pleural TB, and pain, joint swelling, and hampered mobility, draining 
sinuses and abscesses in chronic cases of Skeletal TB. 
2.3 Epidemiology 
The resurgence in the incidence of TB across the world has spurred research efforts to 
understand the epidemiology and pathogenesis of this disease [Burgos and Pym, 2002]. 
Human death as a result of infections and complications from TB is second only to that 
of HIV/AIDS, with about 1.7 million human deaths recorded in 2004 [Cole et al., 1998; 
WHO, 1998]. About one-third of the world's population have latent TB infection; about 
14.6 million people have active TB disease and a there is an annual incidence rate of 
about 9 million [Kurup and Chan, 2006]. Expectedly, the incidence rate reveals a direct 
relationship between the level of economic development and level of TB infection of the 
area [Blower et al., 1995]. For instance, the figures range from 356 per 100,000 in Africa; 
41 per 100,000 in the Americas; to about 90 per 100,000 in the UK [Bradford et al., 
1996]. 
Figure 2.1 shows the trend of notification of TB in WHO regions. While the figures for 
most of the regions are relatively stable over time, a drastic increase was recorded for 
Africa, leading to the World Health Organization declaring the region a TB epidemic 
area. This trend largely revealed that the current TB control measures are so far 
ineffective, which may be a direct consequence of the worsening HIV/AIDS epidemic in 
Africa [Nahid and Daley, 2006; Nunn et al., 2005; Barnes et al., 1991]. Figure 2.2 shows 
the percentage contribution of cases for WHO regions to TB notification in 2004. Africa 
alone contributed 24% of the total in 2004, and the majority of the top 12 counties are in 
the SADC region of Africa. Figure 2.3 shows data for the top 12 countries with the 
highest TB case notification rates per 100,000 in Africa for the year 2004. 
The study of TB epidemiology is aimed towards enabling a more detailed understanding 
of the inter-relationships between M. tuberculosis and the host in each community in 
question and under natural conditions, that is, in the absence of any interventions 
[Styblo, 1985; Styblo 1984 cited by Murray and Nardell, 2002]. While a detailed 
elucidation of the transmission pathway of the diseases within populations is essential for 
evolving successful treatment and control measures, there are limited tools and 
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Figure 2.1: World TB notification rate per 100,000 population size 
[Source: http://www.afro.who.intitb/notl ficationtrend.html] 
Figure 2.2: WHO Regions percentage contribullon to TB notification in 2004. AFR-
Africa: EUR-Europe: AMR -America: EMR- Eastern Mediterranean : SEAR - South 
East Asia and WPR - Western Pacific regions respectively 










e ha :>ter 2 SLJ rvey of Li teratLJre 
--------------------
Swazj .. rd 
N"", lIJ ia 
LeSUl10 
---_.- ..... . . 
BoIs"", ,,,, 
SWtl, AI,,," 
t Za rro" 
0 Z", ~" bwe , 
0 Kenya U 
C. Br= .. ., 
M;J ",'" 
,,",» u ;;-, 
~~, 
Rail! per 100,000 
Figure 2.3: Top 12 countries with highest T8 notification rates. African Region 
2004. [Source: http://www.afro.who.intltb/burdenreporting.html] 
2.3.1 Drug and Multi- Drug Resistant Tuberculosis 
The world wide increasing inddence of T8 can be attributed to the emergence of drug 
reSistant strains of M. tuberculosis (MTS). Drug resistant tuberculosIs (ORT) is defined 
as TS cases with positive cu lture for an M Wberculosis strain that was resistant to any of 
the drugs isoniazid. nfampin. ethambutol or streptomycin [GranlCh et al. 2000; Park et 
al . 1996]. The first case of Mycobacterium tuberculosis resistance to drugs occurred not 
long after the discovery of streptomYCin in 1944 [Croflo and Mitchison. 1948 dted by EI 
Sahly et ai, 2000] 
There are two types of DRT: primary and secondary (or acqlJired) resistance. While 
primary ORT develops in persons who are initi ally infected with reS istant stra,ns of M 
Wberculosis, secondary ORT. or acqlJ ired res istance, occurs during T8 therapy. 
AcqlJired resls/ance results if. during the treatment period. the pat ient was trealed with 
an inadequate regimen or if the patient failed to complete the prescribed regimen 
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Multi-drug resistant tuberculosis (MDRT) is defined as TB caused by strains that 
manifest a high degree of resistance to both isoniazid and rifampin, whether there is 
resistance to other drugs or not [Ormerod, 2005; Pearson et al., 1992; Dooley et 
al., 1992b]. The emergence and worsening menace of drug (and multi-drug) resistant TB 
poses a serious threat to the effectiveness of the treatment protocol and the control 
measures for TB [Grannich et al., 2000; Beck-Sague et al., 1992]. 
In 1991, the Centre for Disease Control [CDC, 1992] conducted a survey across the 
United States. It found that 14.4% of new TB cases tested had organisms resistant to at 
least one anti-tuberculosis drug and 3.3% had MTB strains that are resistant to both 
isoniazid and rifampin. This is a far cry from a figure of about 0.5% recorded for the 
period 1982 through 1986. A similar alarming trend is noted for recurrent TB cases as 
well. Worthy of note is that the problem of DRT and MDRT is most prevalent in 
developing countries, accounting for about 90% of the reported cases [Ormerod, 2005]. 
2.3.2 Tuberculosis and the HIV epidemic 
A critically important factor in the epidemiology of TB worldwide is HIV/AIDS [Comstock, 
1999; Coronado et al., 1993]. TB has been reported to be accountable for about 35% of 
deaths of AIDS victims. In Sub-Saharan Africa about 75% of individuals with tuberculosis 
are co-infected with HIV [Dlodlo et al., 2005]. Figure 2.4 shows the estimated TB 
incidence in HIV positive adults per year for South Africa. 
The immune mechanisms of an HIV-1 infected host that lead to the progression of latent 
to clinically active mycobacteria is still being actively debated [Shen et al., 2004]. It is 
believed however that because of its adverse effect on the immune system, HIV infection 
facilitates acquisition of tuberculosis infection [Dlodlo, et al., 2005; Shen et al., 2004]. Co-
infection with HIV is the most powerful risk factor associated with progression of latent 
TB infection to active tuberculosis. In effect, HIV serves to catalyze the acquisition and 
progreSSion of TB and has been shown to be an important single-factor contributor to the 
spread of multi drug resistant TB strains (MDRT) [Small et al., 1993]. 
It was found that latent TB infection in HIV positive patients is much more likely to 
progress to active tuberculosis compared to HIV negative ones. This phenomenon 
seems to be responsible for the high TB incidence and fatality rate in sub-Saharan Africa 
[WHO, 2003]. About 9 percent of new TB cases in 2000 were attributable to HIV. 










the HIV epidemic. In Sub-Sahar.m Africa, for example, some 31 percent of new TB 
cases are due to TB-HIV cO-infection [Narain,1992]. 
Year 
Figure 2.4 ' South Africa TB notification in HIV+ adults (V\'HO, 2006] 
2.4 Bacterial Genomics 
Bacteria are of immense importance because of thei r adaptability and capaCity for rapid 
growth and reproduction ["Ni lson €Or il/ •. 2002] While some are responsible for causing 
disease in other forms of life, other bacteria sel'le as sources of antibkltics, for instance 
streptomycin and nocardicin [Holt. 1994] . Some bacteria live symbiotically in the guts of 
human and rmmufaclure Vitamin K. an essential blood ciottin9 factor [Davidson, 20061. 
Others live in and/or on animals and on the roots of certain plants, converting nitrogen 
into a usable form [Adams, 2003; Holt. 1994]. Bacteria are also used for the production 
of desirable flavours in food production and to help break down dead organic matter 
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Genomics studies provide us with insightful details into how an organism functions, their 
genetic constitution, origin and evolution and their species diversity [Ward and Fraser, 
2005]. Bacterial genomics is the study of bacteria using information derived from 
understanding the bacterial genome and its DNA sequence [Overbeek et al., 2005]. A 
genome contains the complete hereditary information (both coding and non coding) of an 
organism that is encoded in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) [Mora 
et al., 2006]. Genomics studies provide a means of gathering information regarding the 
functional interactions between genes in an organism and genome relatedness, and as 
such, establish the commonality and differences in all forms of life [Ward and Fraser, 
2005]. The ultimate goal of microbial genomics studies is to be able to make distinctions 
between genes that are essential for growth or those responsible for virulence. They can 
also facilitate the identification of the genetic differences between several genomes from 
the same species [Mora et al., 2006; Overbeek et al., 2005]. 
Over 300 bacterial and archaeal genomes that cut across wide species and strains of the 
same species have been successfully sequenced [Binnewies et al., 2006]. The genome 
databases are expected to include about a thousand species soon [Field et al., 2006; 
Overbeek et al., 2005]. Genomic information has provided significant insights into the 
physiology and pathogenicity of many organisms. For instance, direct sequence analysis 
allows for genome-level analysis of pathogens, in particular those that are not amenable 
to genetic manipulation [Raskin et al., 2006]. Such studies will also allow for examination 
of small differences such as single nucleotide polymorphisms (SNPs). 
The development of gene cloning and sequencing techniques revolutionized the 
discipline of molecular biology [Efstratiadis et al., 1977], providing researchers with a 
large and growing database of complete genomes of the smallest of prokaryotes to more 
complex ones [Edwards et al., 2006]. Of significant note are the new sequencing 
technologies that allow for sequencing of random community DNA and single cells of 
bacteria, without the recourse to cloning or laboratory CUltivation [Shendure et al., 2005; 
Clarke, 2005 cited by Edwards et al., 2006]. At present about 405 published complete 
genomes are available on the Genome On Line Database (GOLD) with a far larger 
number on stream as a direct consequence of improved new ultra-high-throughput 
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Cutting out the need for laborious laboratory experimentation, genomic analyses enable 
a rapid elimination of poorly conserved targets among various genomes and hence 
identification of well conserved genes and cis regulatory elements [Sturino and 
Klaenhammer, 2006]. The ongoing approach to focus research efforts on community 
whole genome sequencing rather than the present application of metagenomics to assay 
natural microbial communities will make bacterial comparative genomics more relevant 
to the understanding of microbial biology as a whole [Field et al., 2006]. 
2.5 Bacteria Comparative Genomics and Phylogeny 
Comparative genomics dwells upon understanding the function and evolution of 
genomes. For instance, a comparative genomics investigation into the interactions 
between phage and bacteria has been employed to engineer phage protection for 
industrially important bacteria used in bioprocessing activities [Sturino and 
Klaenhammer, 2006]. Many bacterial comparative genomic studies have being carried 
out to elucidate commonality and differences among various species of bacteria and to 
understand evolutionary relationships among these species. This is made possible by 
the employment of rapid methods for comparative sequence analysis of small subunit 
rRNAs [Woese, 1987]. 
Before the genomic era and the subsequent availability of comprehensive sequence 
databases, the phylogeny of bacteria was derived from the 16S rRNA. With the advent of 
comparative genomics and the availability of large sequence data for many organisms, 
this is now accomplished by comparing these sequence data to other potential 
phylogenetic marker molecules. Genomes are an excellent source of phylogenetic 
markers. These informative markers are based on genes and gene products that have 
sufficient sequence conservation and are universally distributed among various 
organisms and include, but are not limited to, large subunit rRNA, RNA polymerase, 
DNA gyrase, recA and tRNA synthetases [Edwards et al., 2006]. For example, Figure 2.5 
shows a maximum-likelihood tree produced from concatenated alignments of the 
universal subset of ribosomal proteins. 
The comparative phylogenetic analysis of these bigger molecular markers is carried out 
as with the small subunit rRNA, save for some minor differences in local tree topologies, 
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comparing a few distinct differences between phylogenetic trees derived from rRNA and 
protein gen€s [Field e/ al., 2006]. Usually there are a large number of genes to work with. 
This may introduce SOITt€ problems in the comparatIve phylogenetic analysis, particularly 
when there are genes that are paralogs from gene duplication events or gen€s that 
originate from horizontal gen€ transfer, The paralog markers can only be recognized as 
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Flgl.lre 2.5: Maximum4ikellhood tre€ produced from concatenated alignrTl€nls of the 
universal subset of ribosomal proteins. The tree is unrooted. The cirdes indicate the 
level of oootstrap SUPp;lrt, with the f""lowlng colour coding' red: 90-100%, yellow: 80-
90%, green' 70---80%, blU€' 60-70"/0, magenta' 40-60% The nodes with <40% suppori 
are unmarked [Wolf et al., 2001 ]. 
However, with the availability of more genome sequences, it is possible to solve such 
problems pract ical ly with the use of genome-wide phylogenetic comparative analysis 
using large subsets C( complete gell€ sets of all completely sequence genomes 
[Schle ifer, 2004]. A conserved gene pair 'In prokaryotic genomes or distributions of 
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has revea led deep evolutionary relationships betvveerr prokaryotic lirreages_ Despite the 
problems with multiple genes and laterat gene transfer in organisms [Yuri et aI., 2001], 
however, distributions of identity with the phylogenetic analyses based upon alternative 
markers showed that small subunit rRNA derived trees globally reflect the phylogeny of 
the corresportding organism, artd locally more their own history [Schleifer artd Ludwig_ 
1999] 
Figure 2.6 shows !he corrected neighbOlJr-joining evolutionary distance tree of the 
bacterial domain from approximately 8,000 bacterial16S rRNA genes with 36 recognized 
divisions and putative candidate gertes. The divisions wh'lch have cultivated 
represerrtatives are showrr irr black: divisions represented only by environmental 
sequences are shown in outline [Pace el ai" 1998], 
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Comparative genomics studies are not only used for phylogeny studies, but have also 
been performed for identification of unique proteins at different levels; between 
pathogens [Prentice, 2004; Gil and Moya, 2004], non-pathogens, [Nascimento et al., 
2004] different species of the same genus [Nascimento et al., 2004; Ferretti et al., 2004; 
Moreira et al., 2004] or between different strains of a species [Mazumder et al., 2005; 
Deng et al., 2003]. Identification of unique proteins at different taxonomic levels has 
provided knowledge about the metabolism, pathogenicity, physiology and behaviour of 
different organisms [Siew et al., 2004]. 
2.6 Mycobacterial Comparative Genomics 
The whole complement of genes present within various mycobacterial species has been 
defined [Cole et al., 1998; Camus et al., 2002, Fleischmann et al., 2002; Cole et al., 
2001; Gordon et a/., 2001] and their sequences compared to other mycobacterial species 
[Fleischmann et al., 2002; Gordon et al., 1999; T0njum et al., 1998]. Figure 2.7 shows a 
comparative phylogenetic tree of selected mycobactera, based on 16S rRNA sequences. 
The sequences of various mycobacterial species have also been compared to those 
sequences from other organisms, including other microbes and pathogens [Brosch et al., 
2001; Cole, 1999]. These studies have the potential to enhance specificity in 
identification of essential genes. Comparative genomics can also assist in pinpointing 
potentially antigenic proteins and narrow down potential targets for new and existing 
drugs and vaccines, as well as providing better diagnostic tools to detect mycobacterial 
infections [Cole, 2002]. 
The complete genome sequence of Mycobacterium tuberculosis (strain H37Rv) consists 
of 4,411,529 base pairs encoding approximately 3,986 proteins. Of these, 2058 proteins 
have a predicted biological function and 376 putative proteins share no homology with 
known proteins [Cole et al., 1998; Camus et al., 2002] The clinical strain, CDC1551, 
consists of 4,403,836 base pairs and approximately 4,187 open reading frames (ORFs), 
with an average G + C content of 65.6%. Predicted biological roles were assigned to 
43% of the ORFs, while 15% have high sequence similarity with hypothetical proteins 
from other species and 42% are regarded as novel genes due to no match to any ORFs 










Ch~ ptff 2: S 'Jrvey of L,ter d ure 
The information revealed by the genome sequence of Mycobacterium tuberculosis has 
provided new and important insights into the biology of the tuberde bacillus and 
highlighted the significance of lipid metabolism to its way of life (about 8% of the genome 
is devoted to this activity) [Cole et ai" 1998)_ While the cell envelope of M tuberculosis 
was known to coota in a nota~e numbers of lipids [Daf/e and Draper, 1998]. the genome 
5equence exposed many of the genes eS5entlal for their production , It was a surprise to 
find several genes and proteins that could code for enzymes that wtalyze alternative 
sources of carbohydrates. that is a high number of enzymes involved in alternative lipid 
degradation from the host cell, which has not been reported in other bacteria 
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Figure 2.7: Phylogenetic tree of selected mycobacteria based on 165 rRNA 
sequences, Those shown in red and green are spec'I€S whose genomes have been 
completely sequenced [Brosch et 8/ . 2001]_ 
Despite Mycobacterium tuberculosis using lipolysis as its primary catabolic pathway, it 
also has a set of biosynthesis genes that are commoo to soil organisms Involved in 
degradation of xenobiotics and modifkation of organiC molecules to carbohydrates, This 
suggests the presence of a complete anabolic pathway, which supports the hypothesis 
that the tubercle bacillus has recently emerged as a human pathogen or that it has 
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the latter justification is provided by evidence that genes for anabolic functions have 
been greatly preserved in the genome of Mycobacterium leprae, a related obligate 
intracellular pathogen, despite massive reductive in the M. leprae genome compared to 
M. tuberculosis [Cole et al., 2001; Eiglmeier et al., 2001]. 
The genome sequence also enabled identification of some novel gene families which 
were either unknown before or poorly understood. Among these, the major ones are the 
Pro-Glu (PE) and Pro-Pro-Glu (PPE) families, including about 100 and 67 members, 
respectively [Cole et al., 1998], which correspond to about 8% of the genome. Members 
of each of these families share a conserved N-terminal domain of about 110 and 180 
amino acid residues, with the characteristic motifs 'Pro-Glu' (PE) or 'Pro-Pro-Glu' (PPE) 
at positions 8 to 9, or 8 to 10, respectively. The families are further subdivided into 
smaller groups, based on their C-terminal domains. Among the PE family are the 
polymorphic GC-rich sequence (PGRS) and major polymorphic tandem repeat (MPTR) 
subfamilies. The PE and PPE families are discussed in more detail below. 
Various comparative and functional genomics approaches such as proteomics, 
bioinformatics, structural biology, transcriptomics, and microarray analysis have been 
performed on mycobacterial species to understand the evolution of these pathogens 
[Brosch et ai, 2001; Cole et al., 1998; Supply et al., 2000] and their interaction with their 
various hosts [Camacho et al., 1999]. In silico comparative sequence analysis of M. 
leprae and M. tuberculosis provides evidence for reductive evolution in the former, that is 
genes becoming pseudogenes or inactive as functions are no longer required in highly 
specific niches. In M. leprae the total number of genes encoded by the genome is about 
half (1602 genes) that of M. tuberculosis, with 27% of genome coding for pseudogenes 
with functional counterparts in M. tuberculosis [Cole et al., 2001]. 
About 1,400 genes where found to be common between M. leprae and M. tuberculosis, 
of which, 333 were common among Actinomycetes and 219 were specific to the 
mycobacterium complex organisms (Mycobacterium tuberculosis strains CDC1551 and 
H37Rv, Mycobacterium bovis, Mycobacterium leprae and Mycobacterium 
paratuberculosis avium) [Cole et al., 2001; Tekaia et al., 1999]. Since M. tuberculosis 
and M. leprae are both intracellular pathogens, some of these genes might play an 










26 Chapter 2: Survey of Literature 
Moreover, amino acid sequence comparative analysis on a region corresponding to the 
PE and PPE protein families resulted in the identification of the variability and possible 
roles of these multiple gene families when the PE genes of M. tuberculosis strains 
H37Rv and CDC1551 were compared. It was discovered that the genes encoding a PE 
domain alone, or a PE domain followed by a unique protein sequence, were identical in 
both genomes [Banu et a/., 2002; Betts et a/., 2000]. 
In contrast, Banu et al. [2002] found 39 of the 62 regular PE-PGRS proteins displayed 
variability as a result of in-frame insertion or deletion of diverse Ala, Gly-rich coding 
sequences in the PGRS component of the gene, or harbored frame shift mutations. This 
seems to occur with no loss of enzymatic activity due to available evidence that the 
antibodies cross reacted with more than one member of PE-PGRS proteins [Cole, 2002]. 
Potential structural functions were also suggested for this family, as comparative 
analysis observed similarity between the PE-PGRS protein and some structural proteins 
of insects [Cole, 2002]. 
Comparative analysis between these families of proteins and amino acid sequences of 
tandem repeats that have been found to be conserved in some other bacteria and 
Archaea may be useful for detecting related proteins from other genomes, and to assist 
in designing suitable experiments to test their potential functions. Equally important is an 
increased awareness of the diversity and complexity within the genus of mycobacteria. 
This was obtained from the application of comparative studies and molecular techniques 
to the analysis of isolates from environmental and clinical sources. Various evidences 
have shown that gene loss occurred at a high rate within species of the M. tuberculosis 
complex as a result of homologous recombination events [Brosch et al., 2000; 
Fleischmann et al., 2002]. 
Fleischmann and co-workers [2002] compared multiple genome sequences of 
Mycobacteria, including M. bovis and M. tuberculosis clinical and laboratory stains. 
Figure 2.8, taken from their paper, shows a circular representation of the M. tuberculosis 
genome showing the locations of each predicted protein coding region. They observed a 
region with different numbers of genes, which revealed contradictory evolutionary 
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Figure 2.8: The circular representation of the M. tuberculosIs genome 
[Fleischmann et al .• 2002] 
Brosch et a/. [2002] also fouOO the prescnce of intact mmpS6 and mmpLD' genes in M. bovis. 
aOO a truncated region corresponding to these genes in most M tUberculosis strains. These 
show that genetic variability in M tuberculosis arises through complex evotutionary 
processes that involve recombination ot multiplB insertion-delBtion events occurring 
indePBndently at the same locus. suggesting that popular theories of the origin of 
tuberculosis coinciding with the domestication of C<ittle are unlikely to be correct 
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There has also been contradictory evidence in sequence polymorph isms among various 
M tuberculosis complex organisms. For instance, some work recorded the ratio of non-
synonymous substitutions to synonymous substitutions and single nucleotide 
polymorph isms (SNPs) to be silent and much lower than 1.0 [Wade et aI, 2004; Scorpio 
and Zhang, 1996] compared to the 1.0 in 2000 to 4000 base pairs that is generally 
observed among bacteria [Sreevatsan et al., 1997]. 
However, Fleischmann and his colleagues discovered a high degree of sequence 
divergence between multiple genome sequences of M tuberculosis and M bovis. 
M tuberculosis clinical and laboratory stains had an unexpectedly high ratio of 
non-synonymous to synonymous mutations across all coding sequences compared to 
what was previously observed in comparative analysis among M tuberculosis. They 
further observed most of these differences in other clinical M tuberculosis isolates 
tested, suggesting a possible evolutionary hypothesis that the divergence of M bovis 
and M tuberculosis was so recent that there has been insufficient time for purifying 
selection to operate against non-synonymous mutations [Fleischmann et al., 2002]. 
Another important comparative phylogenetic study of Mycobacterium tuberculosis 
species is the resent study by Filliol and his colleagues [Fillol et al., 2006] who analyzed 
various clinical and major M tuberculosis and Mbovis species, single nucleotide 
polymorphism (SNP) markers to classify clinical strains from various geographical sites 
into SNP cluster groups. 
Based on their analysis they observed that M tuberculosis has a stable association with 
human host populations. For instance, strains predominant in an environment depend on 
the origin and diversity of people in the environment, for example they discovered that 
the United States M tuberculosis isolates showed more diverse cluster groups due to 
large immigrant populations compared to isolates obtained from the same indigenous 











Comparative Genomics Analysis 
The rapidly emerging field of comparative genomics has already yielded dramatic 
results. .......... study comparing the fruit fly genome with the human genome 
discovered that about 60 percent of genes are conserved between fly and 
human . ... , the two organisms appear to share a core set of genes. 
- NHGRI, 2005 
The first major objective of this project is to generate a phylogenetic profile to catalogue 
microbial genes and answer the following questions: 
• What is the phylogenetic profile of all microbial genes? 
• What genes are common to all pathogens and absent from non-pathogens, and 
which genes are unique to M. tuberculosis? 
3.1 An Overview 
In this chapter we provided a phylogenetic profile of all 84 bacterial genomes involved in 
this project and used the output to: 
• catalogue all 246573 proteins into a phylogenetic profile 
• identify genes that are conserved in all bacteria studied 
• identify genes that are unique to pathogens 
• identify genes that are unique to Mycobacterium tuberculosis complex organisms 
• Identify genes that are potentially involved in virulence in the reference genome (M. 
tuberculosis strain CDC1551). 
To achieve these goals, it was necessary to identify sets of homologous clusters of 
proteins between the 84 complete genomes involved and examine the protein clusters 
created for conservation of protein description lines, available functional information and 
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approaches were tested and two sequence similarity-based methods at different levels 
of stringency were decided on to create three sets of phylogenetic profiles of all species 
involved in the experiment. 
We identified sets of homologous clusters of proteins between 84 complete bacterial 
genomes by performing pair-wise comparisons between them using the BLASTP 
algorithm [Altschul, 1990]. This was followed by clustering proteins into related sets 
based on E-value and percentage overlap between two sequences or using the NCB I 
BLASTClust program. This program clusters protein sequences into sets of related 
proteins based on sequence similarity, E-value, percentage sequence identity or score 
density and percentage overlap between sequences [http://biowulf.nih.gov/apps/blast/doc 
/blastclust.html). A phylogenetic profile was generated for each protein cluster in the 
different experiments. The profiles were re-ordered to select the genes of interest. 
3.2 Background 
Comparative genomics analysis is a powerful tool for investigating evolutionary changes 
among (and sometimes within) organisms. It enables the identification of the genes (of 
interest) that are conserved among species as well as the genes that give each 
organism its own unique characteristics. 
Experimentally determined functions are only known for a very small fraction of the 
proteins in sequenced genomes. There is a need for automated methods of transferring 
knowledge from well studied organisms to less known organisms, given the increased 
amount of sequence data from completely sequenced genomes. Since in vivo 
experiments of all genes are not feasible, the ability to infer the function of genes from 
the function of corresponding genes in model organisms is highly desirable. So far, the 
genomes from more than 150 genomes of bacteria have been fully sequenced. Of 
particular interest for human medical research are the full genome sequences of human 
and human pathogens, such as Mycobacterium, Bacillus, Salmonella, Haemophilus, 
Clostridium species, as well as various non human pathogens. 
Many approaches have been used to infer functional linkages between genes within the 
genome of the same and different organisms [Groenen et aI, 2006]. Using phylogenetic 
profiles is a common approach to infer function, comparable to the study of comparative 
genomics using the evolutionary concept of homology. To make comparative genomics 
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genes in different genomes that might be functionally equivalent, that is, orthologs or co-
orthologs. This will help in reducing individual experimental analysis to be performed to 
the number of identifiable clusters of orthologs in genomes being compared [Koonin, 
2005]. 
The term homolog refers to genes in different species that are derived from a common 
ancestor Homologous genes are usually observed on the basis of statistically significant 
sequence similarity to a gene or protein of interest. Orthologs are homologous genes or 
protein sequences that evolved by vertical descent from a single ancestral gene, in 
different species that are derived from a common ancestor. They usually occur as a 
result of a speciation event. Orthologous genes mayor may not have the same function, 
but are usually assumed to have maintained equivalent functions. History of the gene 
reflects the history of the species; here phylogeny of genes represents the true 
phylogeny of species. Paralog is used to describe homologous genes within a single 
species that result from a duplication event within a genome. It usually leads to functional 
specialization in which one of the genes evolves a new function through random 
mutation, or both genes share the function of the original gene [Fitch, 1970]. 
Ortholog and paralog formation might be considered to be the primary events of genome 
evolution and have been well recognized in the pre-genomic era [Koonin, 2001]. The 
concept of orthology arises as a result of describing evolutionary relationships with 
accuracy [Fitch, 2000]. It is important in inferring gene functional conservation as a 
consequence of orthology based on sequence similarity. Functional equivalence of 
orthologous genes, which is one of the important properties of orthologs, is theoretically 
plausible and has been experimentally supported in various studies [Amos et al., 2004; 
Koonin, 2005]. These genes typically perform similar functions in the respective 
organisms. 
Orthology identification is further complicated by other primary elements of gene 
evolution such as in-paralogs, paralogs that occur after speciation; and out-paralogs, 
paralogs that precede speciation [Sonnhammer et aI, 2001]; horizontal gene transfer; 
gene loss; gene fission and fusion and gene rearrangement [Doolittle, 2000; Koonin, 
2005]. Since orthology and paralogy are evolutionary events, the best method of 
identifying orthologs is through phylogenetic analysis, or tree reconciliation [Page and 
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compared with a chosen species tree. This is carried out using the parsimony 
reconciliation principle through selecting the number of allowed minimum duplication and 
gene loss events. This approach is expected to show orthologous relationships, however 
there are major shortcomings with this method of orthology inference, principally among 
which is the prevalence of gene acquisition through horizontal gene transfer, xenology. 
Xenolog describes the relationship between two genes in which one has been derived 
by horizontal gene transfer. This phenomenon is very common in prokaryotes and 
makes tree reconciliation a difficult task [Ragan, 2001; Garcia-Vallve et a/., 2000; Koonin 
et a/., 2001; Doolittle, 1999], leading to the use of consensus trees from various genes. 
This is done, for example, by construction of several individual gene trees, and 
comparing the trees to produce a consensus tree [Doolittle, 1999; Koonin, 2005; 
Doolittle, 2000; Wolf et a/., 2002; Daubin et a/., 2002; Bininda-Emonds et a/., 2002]. 
Eukaryotic phylogeny also faces the major issue of uncertainty of artefacts, a problem 
relating to the evolutionary clock which is the dating of speciation events and gene 
fission and fusion (where a protein might be a part of multi domain protein and vice 
versa). While phylogenetic analysis can help to resolve some of these issues, the major 
problem of phylogenetic comparative analysis is the inability to automate the process, 
and the high cost of the computational analysis. 
3.2.1 Principles and Techniques for Identification of Orthologs and Para logs 
In solving the above problems, most computational comparative analyses of genomes 
resort to a more straight forward sequence similarity method to infer orthologs between 
the genomes. The assumptions are that orthologs (genes) sequenced from different 
species are more similar to each other in sequence than paralogs from the same or 
different species [Tatusov et a/., 1997; Koonin, 2005]. The level of functional 
conservation between orthologous proteins makes orthology widely used in genome 
analysis for protein function prediction and annotation, where the information about a 
statistically significantly similar protein sequence from a well studied species is used for 
annotation of the orthologous protein in another species [Groenen et a/., 2006]. 
The concept of identification of orthologous relationships between genes is probably the 
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are well studied and can be used to elaborate on gene functions for most completely 
sequenced genomes. Inferring orthology, coupled with further annotations like structural 
similarity and expression data, can be used to ascertain functional similarity between 
genes. For example, the level of protein-protein interactions, allows networks of 
orthologous sequences to be investigated to detect conservation of processes and 
pathways [Groenen et al., 2006]. 
The concept of the Reciprocal Best Hit, (RBH) technique is the most frequently applied 
method to infer ortholog pairs. In this method, orthologous genes form reciprocal best 
hits (RBH) when the genomes are compared. For example, gene X used as query 
sequence from genome A has the highest sequence similarity score with gene Y in 
genome B and gene Y as query has gene X as its best score. This assumption is based 
on the evolution of orthologs and the possibility of them occupying the same functional 
niche in their individual genomes [Koonin, 2005]. Though the sequence similarity 
approach faces various problems of false positive and negative results due to the 
inherent evolutionary problems of out-paralogs, in-para logs [Koonin, 2001 ; 
Sonnhammer, 2001] and xenologs, genes forming RBH in terms of functional similarity 
are still considered to be orthologs due to their species to species origin of transfer. 
While out-paralogs might not be regarded as orthologs, in-paralogs are considered to be 
orthologs since duplication occurs after speciation. There is practical evidence of genes 
from closely related species forming RBH [Tatusov et al., 1996]. For example, Koonin 
[2005] shows that RBH is common among prokaryotic genomes and it decreases as the 
evolutionary distance between organisms increases. As mentioned previously, however, 
the conventional RBH method faces the issue of in-paralogs when comparing two 
genomes and it also becomes more difficult to rely on when comparing multiple genomes 
due to the complex mix of in- and out-paralogs. 
Various other methods for identification of orthologs, based on specially designed 
sequence clustering procedures, explicit phylogenetic analysis, or a combination of both 
have been developed to solve these problems and better unravel orthologs and paralogs 
[Tatusov et al., 1997; Sonnhammer et a', 2001; Li et aI, 2003; Zmasek and Eddy, 2002]. 
A Cluster of Orthologous Groups (COG) is the first representative of such systems 
[Tatusov et al., 1997]. The COG (and KOG) database is a collection of BLAST-based 
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It is based on the assumption that any set of at least three proteins from fairly distant 
genomes that are more similar to each other than they are to any other proteins from the 
same genomes are the most probable orthologs. Here the notion of a genome-specific 
best hit was extended to multiple genomes such that the algorithm sought to distinguish 
clusters of triangles of mutually consistent, genome-specific best hits. Highly similar 
proteins from the same genome that are more similar to each other than they are to any 
proteins from other species are treated as one [Tatusov et al., 2001]. 
Another popular approach developed by the Inparanoid group formed by Sonnhammer 
and co-workers, identified orthologs and in-paralogs between two genomes A and B, by 
determining all possible pair-wise similarity scores between genome A-A, B-B, A-B and 
B-A that score higher than a preset cut-off of BLAST bit score and overlap. Then, the 
RBH, are marked as potential orthologs. The in-paralogs that score higher than these 
orthologs are then regarded and marked as additional orthologs with a confidence value 
chosen upon the developed statistical criteria. The quality of in-paralogs can also be 
assessed by an out-group proteome score [Remm, 2001). OrthoMCL [Li et al., 2003] 
also takes the result of all-against-all BLASTP and group orthologs and paralogs with a 
Markov Cluster algorithm based on probability and graph flow theory. It allows 
consecutive classification of global relationships in a similarity space. 
The steps involve all-against-all BLASTP, after which, the reciprocal best hits between 
species are marked as putative orthologs and the reciprocal better similarity hits within 
species that are better than RBH are marked as recent para logs. A similarity matrix is 
calculated, followed by a Markov clustering which determines the orthologous groups [Li 
et al., 2003]. Another effort by Sonnhammer and co-workers uses a phylogenomic 
procedure for inference of orthologs by comparing gene trees with species trees, and 
selecting the subset of the gene tree that has the same topology as the species tree, as 
orthologs [Storm and Sonnhammer, 2002). 
Zmasek and Eddy [2002] used the output generated via multiple alignments and 
subsequent tree calculation to automate the ortholog detection procedure. Other groups 
use pair-wise sequence similarity or phylogenetic trees coupled with genome positional 
information to cluster genes into ortholog sets [Overbeek et al., 1999; Cannon and 










Chapter 3: Comparative Genomics Analysis 35 
of genes from different organisms that occupy the same regions and are similar in 
organization are orthologs. 
In this work, we decided not to use reciprocal best hit (RBH) methods or other ortholog 
searching algorithms for a number of reasons. Firstly, as mentioned above, ortholog and 
paralog prediction is not straight forward, particularly in prokaryotes, where this is 
complicated by horizontal transfer and other genetic rearrangements, as well as in- and 
out-paralogs. Secondly, our interest is on proteins that are in any way functionally 
related, not just strict orthologs. These include proteins that might be important for 
pathogenicity and virulence of Mycobacterium tuberculosis, which might include both 
orthologs and paralogs from the same and different organisms. Whereas ortholog 
prediction is used primarily for functional annotation and thus needs to be strict, in this 
study we wanted to identify protein sets that have some potential to now or previously 
share a similar function, without missing any potential functional links. 
Finally, since the evolution of M. tuberculosis is thought to be relatively recent, it is 
possible that paralogs would not yet have had sufficient time to evolve completely new 
functions. We therefore decided to use BLAST and clustering algorithms and 
confirmation by InterPro matches (protein signatures are able to detect functionally 
related proteins, and those that are more distantly related), and not try to separate 
closely related orthologs and paralogs. In this way, when we attempt identify proteins 
unique to pathogens, they should truly be unique in sequence and thus function. 
3.2.2 Possible problem with using BLAST to infer Orthologs 
Orthologs based on BLAST are usually selected based on E values, which depends on 
(and is affected by) the length of the match sequences. Since BLAST generates several 
high scoring segment pairs (HSPs) for each pair of genes and the HSPs may overlap 
with each other, a simple addition of their scores may overestimate the similarity between 
the two genes. 
The best hit for a particular protein may be a local domain hit of a multiple domain 
protein, which may lead to predicted genes being gene fragments and not the true length 
of the gene. These problems were solved by calculating the percentage alignment 
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3.3 Tools Selected for Generating Clusters 
3.3.1 Sequence Alignments 
Biological sequence alignment is the method of comparing two (pair-wise alignment) or 
more (multiple sequence alignment) biological sequences by searching for a series of 
individual characters or character patterns that are in the same order in the sequences 
[Mount, 2001]. Alignment methods are further divided into global and local alignments. In 
global alignments an attempt is made to match the entire sequence onto each order 
using as many characters as possible, extending to both ends of each sequence. 
Sequences that are similar and more or less the same length are suitable candidates for 
global sequence alignment. 
In local alignments, stretches of sequences with the highest density of matches are 
aligned, thus generating one or more islands of matches or sub-alignments in the aligned 
sequences. Local sequence alignments are suitable for aligning sequences that are 
similar along some of their lengths, but dissimilar in other regions and sequences that 
differ in length or sequences that share conserved domains [Mount, 2001]. The primary 
sequence alignment task is to ask if sequences are evolutionarily, structurally or 
functionally related to each other. 
3.3.2 Alignment Algorithms used 
BLAST - The Basic Local Alignment Search Tool is a tool that uses a heuristic algorithm 
to find regions of high local similarity between a protein or DNA sequence and a 
database of sequences [Altschul et a/., 1990], and calculates the statistical significance of 
the matches. It makes a list of all fixed length words (3 for protein and 11 for nucleotides) 
that align with the query sequence with at least some pre-set threshold, and then 
searches through the database to produce high scoring pairs HSP, that have a score of 
at least the pre-set threshold to produce an un-gapped alignment in both directions 
[Durbin et a/., 1998]. The statistical significance of the recorded HSP is evaluated to 
determine whether the match score recorded is higher than what is expected to occur by 
random chance. 
BLASTP - BLASTP uses the BLAST algorithm to compare a query protein sequence 
against a database of protein sequences. Like other BLAST programs, the BLASTP 
algorithm is optimized to find local regions of similarity, but to report a global alignment, 
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BLASTClust - BLASTClust is a single-linkage clustering method to group proteins or 
nucleotide sequences based on pair-wise similarity found using the BLAST algorithm. 
The program accepts as input a file of protein sequences in FASTA format, each with a 
unique sequence identifier. It returns a file of sequence identifiers arranged in clusters. It 
uses the BLASTP algorithm for proteins and MegaBLAST algorithm for DNA sequences 
[http://www.ncbi.nlm.nih.gov/Web/NewsltrISpring04/blastlab.html]. 
For each pair of sequences the top-scoring alignment is evaluated based on several pre-
set parameters, like thresholds, T for score density, S; percent identity, p and alignment 
length, b to control the stringency of clustering. Two sequences are considered to be 
neighbours if the coverage and the score density are over or equal to the pre-set 
threshold. It then assigns a sequence to a cluster if the sequence is a neighbour to at 
least one sequence in the cluster [http://www.ncbi.nlm.nih.gov/Web/Newsltr/Spring04 
/blastlab. htm]. 
3.3.3 Data Sets - Sequence Data 
The data collection steps involved selection and downloading, in FASTA format, of the 
whole genomes of 56 pathogens, including Mycobacterium tuberculosis strain CDC 1551 
(reference genome) and H37Rv. Also included were 3 other species of mycobacteria and 
28 non-pathogenic bacteria including gram positives and alpha, beta, delta, gamma and 
epsilon proteobacteria from the TIGR website [http://www.tigr.org/tigr-scripts/CMR2/CMR 
Home_Page.spl] (Tables 3.1 a and 3.1 b). Non redundant protein sets for the 84 selected 
bacterial genomes were also downloaded from Integr8 project of the European 
Bioinformatics Institute (EBI) [htttp:llwww.ebi.ac.uklintegr8]. 
3.4 Methods 
More than one approach was used to generate sets of homologous genes from the 84 
genomes for the phylogenetic profiles. We used a combination of publicly available 
software and custom scripts to generate three different datasets. In the first method, pair-
wise sequence similarity searches of all non redundant protein sets were carried out by 
creating a local database using formatDB according to NCB I. For every protein in each 
genome, we ran a BLASTP search [Altschul et aI, 1990] against all the remaining 84 
genomes to identify possible homologs with the aid of Python scripts. Homolog sets were 
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~ Blast thresholds set with E-value of less than or equal to 1 e-6 (0.000001) 
~ Percentage [%] alignment coverage: an overlap across the query and hit proteins 
length of greater than or equal to 50%,70% and 90% were tested. 
A group of homolog sets that satisfied the above two criteria were created from the first 
genome, generated from the BLAST output. For each experiment, each cluster was then 
labelled with the aid of a specific identifier. These steps were repeated until all the 
proteins from all genomes had been assigned to a group using each protein as a query 
protein. Redundancy was filtered out by making sure that no protein belonged to two or 
more groups. This was achieved by assigning a protein to group in which it had highest 
significant match. For these homolog sets we then checked whether they contained more 
than one protein from the same organism, that is, potential paralogs, and decided to treat 
the set of para logs as one gene. The above method is referred to as Myblastclust. 
3.4.1 Identification of Clusters with BLASTClust 
The second and third datasets were generated using the Basic Local Alignment Search 
Tool protein clustering program (BLASTClust) from NCB I [http://www.ncbLnlm.nih.gov/ 
BLAST/]. BLASTClust was used to cluster the 246573 protein sequences from all 84 
genomes into clusters of similar homolog sets, with the default E-value of 1 e-6 and 
parameters -p, T, -b, F and -So We selected Score Density option (S) ranging from 0 to 2 
over an area covering 50%, that is -b value of 0.5 for both sequence lengths. For each 
pair of sequences the Score Density, 
N s=--
Ai, 
where, L' is length of sequence in the alignment, L; N is the number of identical residues 
and A is the total alignment length which is equal to L plus number of gaps in the 
alignment. The cluster outputs were examined and clusters with 0.5S and 1.0S were 
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Table 3.1 a: Organism phylogeny-pathogens 
TAXID Organism code Common name Strain Gram Description 
83332 MYCLEH Mycobacterium tuberculosis H37Rv positive High GC, G+ 
83331 MYCTU Mycobacterium tuberculosis COC1551 positive High GC, G+ 
233413 MYCBV Mycobacterium bovis AF2122/97 positive High GC, G+ 
262316 MYCPA Mycobacterium paratuberculosis k 10 positive High GC, G+ 
272631 MYCLE Mycobacterium leprae TN positive High GC, G+ 
257309 CORDI Corynebacterium diphtheriae NCTC13129 positive High GC, G+ 
267747 PROAC Propionibacterium aenes KPA171202 positive High GC, G+ 
203267 TROWT Tropheryma whipplei Twist positive High GC, G+ 
169963 TROW8 Troplerma whippJie two/27 positive High GC, G+ 
195102 CLOPE Clostridium perfringens 13 positive Low GC, G+ 
212717 CLOTE Clostridium tetani E88 positive Low GC, G+ 
261594 BACAN Bacillus anthracis Ames positive Low GC, G+ 
222523 BACC1 Bacillus cereus ATCC10987 positive Low GC, G+ 
158878 STMM Staphylococcus aureus Mu50 positive Low GC, G+ 
12228 STAES Staphylococcus epidermidis ATCC positive LowGC, G+ 
272626 LlSIN Listeria innocua CLIP 11262 positive LowGC, G+ 
169963 LlSMO Listeria monocytogenes GSC1 positive Low GC, G+ 
243273 MYCGE Mycoplasma genitaJium G-37 positive Low GC, G+ 
272634 MYCPN Mycoplasma pneumoniae M129 positive Low GC, G+ 
272633 MYCPE Mycoplasma penetrans HF-2 positive Low GC, G+ 
171101 STRR6 Streptococcus pneumoniae R6 positive Low GC, G+ 
208435 STRA5 Streptococcus agalactiae 2603V/R positive Low GC, G+ 
210007 STRMU Streptococcus mutans UA159 positive Low GC, G+ 
700294 STRP1 Streptococcus pyogenes SF370/ATCC positive Low GC, G+ 
226185 ENTFA Enterococcus faecaJis V583 positive Low GC, G+ 
243274 THEMA Thermotoga maritima MSB8 negative Thermatogs 
272561 CHLTR Chlamydia trachomatis seravar 0 negative Chlamydia 
243161 CHLMU Chlamydia muridarum Nigg negative Chlamydia 
115713 CHLPN Chlamydia pneumoniae CWL029 negative Chlamydia 
227941 CHLCV Chlamydophila caviae GPIC negative Chlamydia 
198214 SHIFL Shigella flexneri 301 negative Gamma Proteo 
83334 EC057 Escherichia coli 0157:H7 VT2-Sakai negative Gamma Prateo 
187410 YERPE Yersinia pestis KIM5 negative Gamma Prateo 
273123 YERPS Yersinia pseudotuberculosis IP32953 negative Gamma proteo 
99287 SALTY Salmonella typhimurium LT2 SGSC1412 negative Gamma Prateo 
601 SALTI Salmonella typhi CT18 negative Gamma Prateo 
32741 SALCH Salmonella choleraesuis SC-B67 negative Gamma Prateo 
233412 HAEOU Haemophilus ducreyi 35000HP negative Gamma Proteo 
71421 HAEIN Haemophilus influenzae KW20 Rd negative Gamma Prateo 
272843 PASMU Pasteurella multocida PM70 negative Gamma Proteo 
243277 VIBCH Vibrio cholerae EI Tor N16961 negative Gamma Prateo 
223926 VIBPA Vibrio parahaemolyticus RIMO 2210633 negative Gamma Prateo 
196600 VIBVY Vibrio vulnificus YJ016 negative Gamma Prateo 
243233 METCA Methylococcus capsulatus Bath negative Gamma Prateo 
242231 NEIGO Neisseria gonorrhoaeae FA1090 negative Beta prateo 
122586 NEIME Neisseria meningitidis MC58 negative Beta proteo 
520 BORPE Bordetella pertussis Tohama I negative Beta prateo 
257311 BORPA Bordetella parapertussis 12822 negative Beta prateo 
243160 BURMA Burkholderia mallei ATCC:23344 negative Beta prateo 
12472 CHRVO Chromobacterium violaceum ATCC:12472 negative prateo 
782 RICPR Rickettsia prowazeki Madrid E negative proteo 
781 RICCN Rickettsia conorii Malish 7 negative proteo 
29461 BRUSU Bucella suis 1330 negative prateo 
29469 BRUME Brucella melitensis 16M negative prateo 
11168 CAMJE Campylobac jejuni NCTC11168 negative proteo 
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Table 3.1 b: Organism phylogeny-non pathogens 
TAX 10 Organism code Common Name Strain Gram Description 
63363 AQUAE Aquifex aeolicus VF5 negative Thermophile 
1299 DEIRA Deinococcus radiodurans R1 positive Deinoc/therm 
1718 CORGL Corynebacterium glutamicum ATCC 13032 positive High GC, G+ 
152794 COREF Corynebacterium efficiens YS-314 positive High GC, G+ 
1902 STRCO Streptomyces. coelicolcr A32 positive High GC, G+ 
33903 STRAW Streptomyces.avermitilis nil positive High GC, G+ 
216816 BIFLO Bifidobactarium.longum NCC2705 positive High GC, G+ 
1488 CLOAB Clostridium acetobutylicum ATCC824 positive Low GC, G+ 
1423 BACSU Bacillus subtilis 168 positive LowGC, G+ 
86665 BACHD Bacillus halodurans C-125 positive Low GC, G+ 
182710 OCEIH Oceanobacillus iheyensis HTE831 positive Low GC, G+ 
1590 LACPL Lactobacillus plantarum WCFS1 positive Low GC, G+ 
33959 LACJO Lactobacillus johnsonii NCC 533 positive Low GC, G+ 
1360 LAC LA Lactococcus lactis lactis IL 1403 positive Low GC, G+ 
97948 PSEAE Pseudomonas aeruginosa nil negative Gamma Prateo 
76868 PSEPK Pseudomonas putida KT2440 negative Gamma Prateo 
98794 BUCAP Buchera aphidicola sg negative Gamma Prateo 
118099 BUCAI Buchnera sp. APS negative Gamma Prateo 
562 ECOLI Escherichia coli K12 negative Gamma Prateo 
36870 WIGBR Wigglesworlhia glossinidia brevipdpis negative Gamma Prateo 
915 NITEU Nitrosamonas europaea ATCC 19718 negative Beta prateo 
155892 CAUCR Caulabacte crescentus CB15 negative Alpha pratea 
375 BRAJA Bradyrhizobium japonicum USDA 110 negative Alpha prateo 
882 DESVH Desulfovibrio vulgaris Hildenboraugh negative Delta prateD 
35554 GEOSL Geobacter sulfurreducens PCA negative Delta prateD 
844 WOLSU Wolinella succinagenes DSMZ 1740 negative Epsilon proteo 
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3.4.2 Creating Matrix and Ordering of Result 
The results from the clustering experiments were entered into a binary matrix of zeros, 0 
and ones, 1 as well as additional matrices with the actual number of proteins, with the aid 
of PYTHON scripts. In each matrix the cluster identifiers are down the first column while 
the organisms' codes are across the first row. In the binary matrix, for each organism, 1 is 
entered into the column of that organism if it has a protein present in the corresponding 
cluster and 0 if it does not, and the case of the other matrices, the number of proteins 
present in the cluster was entered. 
The total number of proteins from all organisms, and the total number from pathogens 
and non-pathogens present in each cluster were evaluated by summing up across 
corresponding rows. A summary matrix was then created to include additional information 
like average number of proteins per cluster and presence or absence of the reference 
organism in each cluster. The matrices were ordered to create static summary tables of 
the total number of clusters, number of single protein clusters, number of pathogen only 
clusters, number of non-pathogen only clusters, number of MTS complex only clusters 
and number of shared clusters by all genomes in the project. 
3.4.3 Selection of genes common to Pathogens and M. tuberculosis 
The columns of the matrices were clustered into pathogens and non pathogens, with 
each set having its total derived from adding together the numbers across each row. 
The rows were then ordered in ascending numerical order based on the total column for 
non-pathogens, followed by ordering the total column for the pathogen set in descending 
numerical order. For the binary matrix, the rows of interest were those containing a total 
of 0 for the non-pathogen set and n, n -1, n - 2, n - 3 etc, for the pathogen set, where 
n, is the number of pathogenic organisms used for the experiments. In this instance, n is 
selected as those proteins common to pathogens and absent from non-pathogens and is 
chosen to be 56. For the numerical matrices, rows with 0 in the total column for non-
pathogens and >1 for the total proteins from pathogens were selected. Those pathogen 
clusters unique to the MTS complex organisms were also selected for further analysis. 
3.4.4 Generation of Virulence Gene Test Sets 
Information on known microbial virulence genes was retrieved using the Sequence 










42 Chapter 3: Comparative Genomics Analysis 
and Pubmed abstracts from NCBI [http://www.ncbi.nlm.nih.gov/entrez/guery.fcgi?CMD= 
Pager&DB=PubmedD. Specific attention was on Mycobacterium tuberculosis virulence 
genes using the following test queries: 
• Mycobacterium tuberculosis and virulence 
• Mycobacterium tuberculosis and pathogen 
• Mycobacterium tuberculosis and host immunity 
• Bacterial and pathogen 
• Bacterial virulence gene. 
3.5 Results and Discussion 
3.5.1 Phylogenetic patterns of proteins in the comparative proteome clustering 
experiments 
Three sets of experiments were conducted - NCBI BLASTClust with Score Density of 0.5 
(0.5S) and Score Density of 1.0 (1.0S), and Myblastclust with E-value of 0.000001 and 
90% alignment coverage (as explained earlier). Results from the three experiments are 
presented. The results of phylogenetic profiles of the proteins for each experiment were 
represented in the form of protein number and binary matrices. Figures 3.1 and 3.2 are 
examples of the results represented as heat maps, which show the number of proteins in 
each organism for individual clusters by the colour intensity. These were obtained by 
converting the numeric number of proteins to a colour code gradient. The colour code 
ranges from green for 0.0, red for 1.0 to yellow for 2 and above; the darker the yellow 
colour the higher the number of proteins in the cluster for that genome. The complete 
matrices for al\ the 84 genomes will be uploaded to the CBIO webpage 
[http://www.cbio.uct.ac.za]. 
Figure 3.3 shows a heat map of hierarchical clustering of the organisms for the first 100 
clusters using the complete linkage algorithm of the TIGR Multiple Experiment Viewer 
(MEV) [Saeed et a/., 2003]. Here the colour code ranges from green for 0.0, black for 1.0 
to red representing 2 and above proteins. 
Table 3.2 shows the general statistics resulting from the clustering experiments and 
Figure 3.4 shows the percentage distribution of cluster types (in terms of organisms 
represented) in each of the experiments. NCBI BLASTclust with 1.0 score density and 
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Figure 3.1: Heat map representation of phylogenetic matrix for 1.0S· The colour code ranges from green for 0.0, red for 10 to yellow for 2 and 
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Table 3.2: General statistical distribution of the experiments 
Experiments 
Total clusters created 
Total Singletons (one protein families) 
Total more than one protein clusters 
Total Pathogen only clusters 
Total non Pathogen only clusters 
Total MTB Complex only clusters 
All organisms (84 genomes) 
All organisms (at least 80 genomes) 
All organism (at least 60 genomes) 
Number with at least two genomes per 
cluster (no paralogs) 
Number of clusters with at least 2 








































of 246573 proteins from 84 genomes, followed by Myblastclust clustering with expected 
value (E-Value) 10-6 and 90% alignment coverage and the NCBI BLASTciust with 0.5 score 
density and 50% alignment coverage with the smallest number of clusters of protein families. 
The Myblastclust clustering gave the highest percentage of orphan families of proteins with 
about 73% of all clusters generated being single protein clusters, followed by 1.0S with 70%. 
The 0.5S results, with the value of 67% of all protein families created being singletons, is the 
lowest. The reverse is the case with the percentage of clusters with more than one protein 
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Table 3.3: The result of known virulence bacterial genes from BLASTClust 1.0S 
Total Virulene 
Total 
Cluste Protein in 
Protein in Average no of 
No of non 
Common e pathogen Common DE line 
r No pathogen organis 
non proteins InterPro 
pathogen s 
s meode s 
14 1117 SALTY 959 34.25 26 ATP-dependent_ Clp IPR001907 
RNA polymerase 
IPR011991, 
29 617 SALTY 506 18.071 25 IPR007624 sigma_factor rpoD IPR007627 
IPR003959, 
131 271 VIBCH 209 7.4643 22 Chaperone_clpB IPR004176 
IPR001270 
I PR002086 , 




366 76 LlSMO 46 1.6429 28 IPR005834 ATPase IPR001757 
522 72 SHIFL 39 1.3929 27 




1052 73 STRR6 29 1.0357 19 IPR006128 adcA_ precursor IPR006129 
Phosphomannomutase/ 
IPR005845, 
2470 51 PASMU 27 0.9643 27 IPR005841 phosphoglucomuta IPR005843 
Virulence factors 
IPR011991, 
4241 34 BACAN 27 0.9643 15 transcription_ regulator IPR001789 
IPROO0792 
IPR001789, 




6264 24 ENTFA 11 0.3929 11 IPR003660 basS/pmrB 
IPR003594 
8270 271 VBCH 209 7.4643 22 Capsule_biosynthesis_capB IPR008337 




10631 4 BORPE 7 0.25 6 Cytotoxic yrotein _ ccdB 
IPR002712, 
IPR011067 




16892 2 BACAN 2 0.0714 2 IPR001638 vgS IPR003661 
30401 2 BACAN 2 0.0714 2 
Attachment_invasion IPROO0758 
_locus precursor 
36375 3 EC057 0 0.0357 0 
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Table 3.4: The result of known virulence bacterial genes from BLASTClust 0.5 S 
Total Virulence 
Total 
Cluster Protein in 
Number of 
organism 







2 1117 54 SALTY 959 26 positive_transcription_regulato IPR001867 
r_bvgA 
5 617 47 SALTY 506 25 
Sensor Jlrotein _ basS/pmrB_ IPR003661, IPR003660 
(EC_2.7.3.-) IPR003594 




60 128 55 LlSMO 67 25 Chaperone_dpB 
IPR004176, IPR003959 
IPR003593 
A TP-dependent_ Clp_ 
144 76 53 LlSMO 46 28 protease_ proteolytic_ IPR001907 
subuniUEC_3.4.21.92) 
176 72 51 SHIFL 39 27 AcyLcarrierJlrotein_(ACP) 
IPR009081,IPR006163 
IPR003231 
201 73 39 STRR6 39 19 
Zinc-binding_lipoprotein _ IPR006127, 
adcAJlrecursor IPR0061281PR006129 
435 51 51 PASMU 27 27 
ATP _synthase....Qamma_chain IPROO0131 
_(EC_3.6.3.14L(ATP _synthas 
675 34 21 BACAN 27 15 
Capsule_biosynthesis _ IPROO0101 
protein_capD 
Phosphomannomutase/phosp IPR005845, IPR005841 
814 34 29 PSEAE 16 14 hoglucomutase _ IPR005843 
(PMM_I_PGM) 
Potassium-transporting_ IPR008250,IPR005834 
1116 24 22 ENTFA 11 11 ATPase_B_chain IPR001757 
_(EC _3.6.3.12) 
(ATP Jlhosphohydrolase_ 
1236 14 8 VBCH 18 7 potassium-
transporting_B_chain) 




2985 4 3 BORPE 7 6 receptor _ bfrD Jlrecursor_ IPR010105 
(Virulence) 
CytotoxicJlrotein_ccdB_ 
5485 4 3 EC057 2 2 (Protein_letS L(Protein _G) IPROO8337 
_(LynB) 
7143 2 2 BACAN 2 2 
Capsule _biosynthesis_ IPR008338 
protein_capB 
8282 2 2 BACAN 2 2 
Capsule_ biosynthesis_ 
protein_capC 
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Table 3.5: The result of known virulence Mycobacterium tuberculosis genes in 1.0 S 
Total Virulence 
Total 
Cluster Number of Protein in No of non 
No Protein in pathogens 
organism pathogens 




29 57 49 ENTIFA 33 26 
RNA -polymerase_sigma_ IPR011991, IPR007624 
factoupoD_ (Sigma-A) IPR007627 
Aldehyde_dehydrogenase_ 
341 22 21 VIBCH 15 12 family -protein/Hypothetical_ IPR002086,IPR012303 
protein 
Potassium- IPR008250,IPR005834 
366 24 22 ENTIFA 11 11 transporting_ATPase _B_ 
chain _ (EC_3.6.3.12) 
IPR001757 
652 16 8 MTB 8 5 
DNA-binding_ IPROO1789,IPR001867 
response_regulator IPR011991 
1583 7 7 MTB 7 4 
Mycobacterial persistence IPR001789, IPR001867 
regulator MRPA IPR005829 




2613 6 6 MTB 4 4 
Cytotoxin_/haemolysin_ IPR002942, IPROO2877 
homologue IPROO4538 
2818 9 5 MTB 0 0 
Virulence_factor_mce - IPR003399, IPR005693 
family-protein 
2820 9 5 MTB 0 0 Mce-family-protein_mce2d IPROO3399,IPR005693 
Phospholipase _ C _1_precurso 
2822 9 3 MTB 0 0 r_ EC_3.1.4.3L(MTP40 IPR007312,IPR006311 
_antigen) 
2823 9 5 MTB 0 0 
Virulence_factor_mce - IPR003399, IPR008360 
family-protein IPR005693 
2931 9 5 MTB 0 0 Mce-family-protein_mce1b_ IPR003399, IPR005693 
3332 8 5 MTB 0 0 
Virulence_factor_mce - IPR003399,IPR005693 
family -protein 
7120 5 5 MTB 0 0 
Heparin-binding_ IPROO0897 
hemagglutinin _(Adhesin) 
8232 4 4 MTB 0 0 Sulfatase family protein IPROO0917 
8234 4 4 MTB 0 0 
Virulence factor mce - IPR003399,IPR005693 
family -protein 
Exported _repetitive -protein-p 
8935 4 4 MTB 0 0 recursor _(Cell_surface_ IPR008165 
protein-pirG) 
11724 3 3 MTB 0 0 
Virulence_factor_mce - IPR003399,IPR005693 
family -protein 
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Number of organism protein in 
No of non 







2 1117 54 SALTY 959 26 
Mycobacterialyersistence_ IPR001789, IPR001867 
regulator _mrpa IPR005829 
49 124 54 MTB 95 27 
RNAyolymerase_sigma_faet IPR011991, IPR009042 
or _rpod _(Sigma-A) IPR007624 
887 27 27 MTB 19 19 
Cytotoxin _/haemolysin _ homol 
IPROO0943,IPR012760 ogue _ (Cytotoxinlhemolysin) 
1679 20 5 MTB 2 2 Mce-family yrotein _mce2d 
IPR002942, IPR002877 
IPR004538 
1681 20 5 MTB 2 2 
Virulence_faetor_mce_ 
IPR003399, IPR005693 family yrotein 
1699 20 5 MTB 2 2 MCE-familyyrotein_mce1 b 
IPR003399,IPR008360 
IPR005693 
1748 19 5 MTB 2 2 
Virulence_factor _mee _family 
IPR003399, IPR005693 yrotein_MCE4A) 
1823 18 5 MTB 2 2 
Virulence_faetor_mce - IPR003399. IPROO5693 family yrotein 
Phospholipase_ C _1 yrecurso 
1883 14 7 MTB 5 4 UEC_3.1.4.3L IPR003399, IPROO5693 
(MTP40_antigen)1 
1905 17 5 MTB 2 2 
Possible_MCE- IPR007312, IPR006311 
family Jipoprotein _Iprm 
5060 6 3 MTB 0 0 
Possible_ virulence- IPR003399, IPR008995 
regulating_38_kDayrotein IPR005693 
Exported _repetitive_protein IPR012287,IPROOOO05 
5995 5 5 MTB 0 0 yreeursor _(Cell_surface IPR009057 proteinyirG) 
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Regarding the extent of genome inclusion in the experiment, 0.58 produced close to 
30% of its clusters with at least two proteins per cluster and with more than one 
organism. 1.08 is the least sensitive with only 20% of the clusters containing at least two 
organisms. In other words, this experiment produces the most exclusive, smallest 
clusters. There were very few clusters covering all organisms, probably because of the 
diversity of taxonomies chosen. 
3.5.2 Detection of paralogs families 
Myblastclust produced the highest number of families of proteins with more than one 
member from the same organism, accounting for 16% of all non singleton clusters. It is 
followed by 0.58 and then 1.08 with only 5.7% paralog clusters in the latter. 
3.5.3 Selection of genes common to pathogens only and those unique to MTB. 
We observed that close to 50% of the clusters with more than one protein created by 
BLA8Tciust with 1.0 are pathogen-specific. This is followed by Myblastclust clustering 
with 41 % of its clusters, while 0.5 created 37% of its clusters as pathogen only clusters. 
The percentage ranges of M. tuberculosis complex only clusters created by the 
experiments were very close but with 1.08 still having the highest percentage (Table 
3.2). 
3.5.4 Production of virulence gene test set 
Known virulence genes were extracted from the literature to form a test set of 38 genes 
from M. tuberculosis complex organisms and 47 genes from other pathogens. The 
phylogenetic distribution pattern of 47 known bacterial virulence genes from pathogens 
other than M. tuberculosis in the test set obtained from PubMed abstracts and 8wiss-
Prot annotation were determined. These bacterial virulence genes were distributed 
between 19 clusters in BLA8Tclust 1.08 and 21 clusters in BLA8Tclust 0.58 
experiments (Tables 3.3 and 3.4 respectively). Of these, 5 clusters from the 1.08 
experiment and 11 from 0.58 include M. tuberculosis complex proteins. 
Three and one clusters of each experiment, respectively, contain proteins that are also 
annotated to be virulence genes in M. tuberculosis complex organisms (Tables 3.5 and 
3.6). The tables show the cluster number, organisms from which the gene was 
characterised as being involved in virulence, and number of other pathogen and non-
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Tables 3.5 and 3.6 show that 38 of the known M. tuberculosis complex virulence genes 
tested were distributed between 19 and 13 clusters in the 1.0S and 0.5S experiments 
respectively. While the virulence genes from other pathogens appear to have familyi 
members in non-pathogens, the M. tuberculosis virulence genes appear to be a bit more 
restricted to pathogens. 
3.6 Discussion 
We have tested two methods of sequence clustering algorithms to detect sets of 
homologs from our 84 selected bacterial genomes. Each was used to create a matrix of 
phylogenetic profiles for all the bacterial proteins and organisms used. The output was 
employed to answer questions related to Mycobacterium complex virulence genes. 
The results show that most of the clusters of more than one protein observed are 
relatively large protein families, with more than one protein from each organism and few 
clusters in each experiment generally contain one protein representative from each 
included species (Figure 3.4). For example, Figure 3.2, shows no green in colour on the 
heat map for 0.5S, which indicates that all the 84 organisms have at least one protein 
present in the fist 100 clusters of this experiment (the hetamaps show only a subset of 
clusters and these are different in both figures). 
In general, the mean number of proteins per cluster of course decreases as the number 
of paralogous proteins from the different genomes decreases and as the number of 
clusters increases (Figure 3.5). A plausible explanation for this relationship in the 
experiments might be that the highly conserved paralogs have retained their original 
functions, while the functions of the less conserved para logs have changed over the 
course of evolution. 
One of the observed large paralog families of proteins is the PE and PGRS protein family 
of M. tuberculosis complex organisms, in which each of the M. tuberculosis complex 
organisms have at least 60 copies of the gene, the exception being Mycobacterium 
leprae. This is consistent with the findings of Gordon et al. [1998] and Cole et al. [1998]. 
They reported the distribution of some novel M. tuberculosis complex gene families 
which were either unknown before or poorly understood. They found that each 
M. tuberculosis complex organism has between 67 and 100 genes, which are annotated 
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0.5S experiment with complex retationships between members (Figure 3.2). FC( 
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domains. This was also observed by Poulet and Cole [1995] HoweYer, it was found that 
the PE and PEIPGRS family seems to include proteins from other pathogenic <lnd non 
pathogenic aclrllomycetes In the 0.5S experiment A recent study showed that the non-
mycobatcteriat prot~ns do not contain the PE domain. and thus may not be true family 
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This observed pattern in the PE/PGRS and other clusters in the case of the 0.5S 
experiment tends to support the postulations that Mycobacterium tuberculosis has a set 
of biosynthesis genes that are common to soil organisms involved in degradation of 
xenobiotics and modification of organic molecule to carbohydrate. This has led to the 
suggestion that the Tubercle bacillus has only recently emerged as a human pathogen 
and still shares some of its genes with non pathogenic organisms from same lineage 
[Cole, 2002]. 
Our results also show that the occurrence of clusters of proteins that are specific to a 
number of pathogens are generally very few in all the clustering experiments tested 
compared to the numbers of pathogens included in the experiments. This is likely to be 
as a result of the diversity of pathogens involved in the study, and the fact that 
phylogenetic profiles usually follow species phylogeny rather than gene functions or 
organism phenotype. Allowing for some non pathogenic organisms genes to be included 
in the study set increases the numbers of clusters which results in a deliberate 
overrepresentation of the pathogens. For most of these clusters, the range of organisms 
included correlated with their phylogenetic lineages (Figure 3.3). 
Pathogen-specific clusters that also contain Mycobacterium tuberculosis genes are 
observed to be very few and include representatives from a very small number of the 
total pathogenic organisms included in the study. The largest Mycobacterium 
tuberculosis containing pathogen-specific cluster observed for the 1.0S experiment 
contains 8 organisms viz: 5 Mycobacterium tuberculosis complex and 3 beta 
proteobacteria pathogens. The 0.5S experiment on the other hand, produced a 9 
organism pathogen-specific cluster as its largest, consisting of 5 mycobacterial, 2 beta 
and 2 gamma proteobacterial genomes. 
A close examination of the clusters that have Mycobacterium tuberculosis genes shows 
that Mycobacterium tuberculosis complex organisms form clusters with other 
actinomycetes (both pathogen and non pathogen) and some other phylogenies, such as 
high and low GC gram positive and beta and gamma proteobacteria (Figure 3.3). 
Interestingly, about 90% of the clusters that contain M. tuberculosis genes are MTB 
complex-specific clusters with only the 5 MTB complex organisms included. The 
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literature allowed for validation of the experimental results and enabled us to examine 
which of the clustering experiments identified known families of proteins correctly. To 
achieve this, we examined the protein description line and InterPro annotations in the 
known bacterial virulence gene clusters. Generally a very good correlation was 
observed, with majority of the member proteins having similar description lines and the 
same InterPro identity. The InterPro matches are more conserved in 1.0S with over 90% 
of the members mapping to the same InterPro families. 
Surprisingly, most of these clusters containing known bacterial virulence genes are not 
pathogen-specific in all the experiments. The distributions of known bacterial genes in 
1. OS shows that out of 19 clusters designated for these proteins only 2 are pathogen-
specific while 0.5S detected only 1 pathogen-specific cluster. It should be note however 
that most of these test set clusters include proteins from organisms with close 
phylogenetic distances in the 1.0S experiment, for example cluster 8270 in Table 3.3 
contains 4 non pathogenic organisms and they are all Bacillus species. 
Examination of known virulence M. tuberculosis genes in all the members also revealed 
a similar description line and they mapped to same InterPro entries with 0.5S seeming to 
combine two or more clusters from 1.0s into a single cluster. Out of the 19 clusters that 
are designated to these known virulence M. tuberculosis genes in 1.0S, 11 of them were 
pathogen-specific and also M. tuberculosis complex-specific, while 0.5S had only 3 of 
the clusters as M. tuberculosis complex specific. 
3.7 Conclusions 
In general, the results of the experiments show that the 1.0S experiment is more 
sensitive and selective, generally including less para logs from closely related genomes 
while 0.5S includes more paralogous proteins and also includes proteins from more 
distantly related organisms. The Myblastclust clustering experiment gave an intermediate 
result. 
Because of the high level of functional similarity between orthologous proteins, the quality 
of orthology prediction is a central aspect in the transfer of functional annotation. To 
generate phylogenetic profiles of all bacterial genomes involved in this project we tested 
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phylogenetic profiles of all species. We measured the functional similarity of proteins 
within clusters using InterPro and Gene Ontology functional data. 
We as well, detected a sensitivity/selectivity trade-off: the functional similarity within a 
cluster of homologs increases when the number of proteins included in the groups 
decreases. The method or amount of stringency to be used is dependent on the research 
question that needs to be answered. It also depends on, for example, the evolutionary 
distance between the studied species and the desired size of clusters, that is many-to-
many or one-to-one orthologous relationships between species. 
From the results we have two sets of genes, from now on referred to as predicted 













"Biology is a discipline rooted in comparisons ....... Genomics is the most recent 
branch of biology to employ comparison-based strategies ... " 
-Nobrega and Pennacchio, 2004. 
The second major objective of the project is to select and characterise potential virulence 
genes in M. tuberculosis by answering the following questions: 
• What genes are potentially involved in virulence in M. tuberculosis? 
• What is the potential role of these genes in virulence? 
4.1 Overview 
In this chapter, in analyzing the clusters generated, we use the hypothesis that 
functionally equivalent homologs should perform similarly in functional characterization of 
the protein set in each cluster. This aspect of conservation of function can be measured 
in various ways, e.g. having similar expression profiles and involvement in the same 
biological and molecular processes (GO annotation). Identical domain annotation 
(InterPro annotations) and conservation of protein interaction [Groenen et al., 2006], 
could also be used to measure function conservation. 
Once the clusters were generated, we were able to determine the best clustering method 
by calculating, for each experiment, the percentage of proteins in each cluster that had 
the same UniProtKB description line, same InterPro accession numbers and those 
involved the same GO slim biological process and molecular function. To achieve this, 
we examined the protein description lines, InterPro annotations and GO annotations and 
calculated the percentage conservation in these functional labels. 
We went on to analyze the functions of predicted clusters by comparing functional 
categories between the predicted and non predicted sets for the 0.5S and 1.0S 
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sets. Since many of the predicted proteins are hypothetical proteins we tried to predict 
functions for some of the unknown clusters. 
4.2 Background 
Homologs are proteins that have a common ancestor or are evolutionarily related. It is 
common that very close homologs, particularly orthologs, frequently have a similar 
function. Homology-based transfer of functional annotations is a raw prediction technique 
that assigns proteins that have not been annotated with the function of their annotated 
homologs. These methods are based on sequence similarity between proteins. 
However, functional inference through these approaches has some short comings as 
well as functional limitations. One major predicament is that it is difficult to be sure of the 
level of sequence similarity to ascertain that two proteins have the same function [Shah 
et aI, 1997]. Other problems of homology-based functional transfer includes common 
errors when transferring annotation based on identifying one domain of multiple domain 
proteins as homologs [Liu et al. 2004]; errors in the original database annotation of the 
homolog; and short comings caused by evolutionary divergence, for example, when the 
closest homologue has lost the function or acquired another function through mutations 
[Yanay et al., 2005]. 
In the absence of high sequence similarity, motifs and patterns can also be used to 
analyze function, by performing multiple sequence alignment of a functionally annotated 
protein family. This can lead to the identification of similar motifs or patterns in a target 
protein. It also allows for annotation transfer from experimentally characterized proteins 
to an unknown protein target even in the absence of a significant level of overall 
sequence similarity. 
Protein Signature databases like Pfam, ProDom and PROSITE are databases that 
provide essential tools for identifying distant relationships in new sequences and thus are 
used for the classification of protein sequences and for inference of functional similarity 
between protein sequences. For instance, PROSITE [Sigrist et al., 2002] contains 
manually chosen biologically important motifs and consists generally of three types of 
signatures: patterns, rules and profiles, with each Signature using a different automated 
method for searching motifs. Although the two most local signatures, patterns and rules, 
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Another important motive-based library is Pfam [Bateman et al. 2004], in which motifs 
usually span over complete domains of at least 100 residues [Liu et al., 2004]. It is based 
on a combination of specialist manual curation and automated analysis. The annotation 
in Pfam includes a description of each family and links to other resources and literature 
references. 
INTERPRO, Integrated Resource for Protein families, domains and functional sites, is a 
database that catalogues information derived from protein signatures. It assembles 
information from various protein signatures databases that each generate protein 
families and domains through different protein signatures methods [Mulder et al., 2003]. 
The InterPro database can be used to assess the conservation of molecular function 
within our homolog sets of proteins because each InterPro accession number represents 
a protein family or domain, containing a cross-species set of homologous proteins with 
its own functional annotation. Proteins within a homolog cluster should belong to the 
same InterPro family and have the same domain compositions. The higher the 
percentage of proteins with the same InterPro accession numbers within a homologous 
set, the better the conservation of function. 
GENE ONTOLOGY - The Gene Ontology (GO) project arose as a result of the need to 
have a common annotation system for describing gene products. It provides structured, 
standard terms for describing the function of gene products. The GO vocabulary is 
divided into three ontologies viz, molecular function, biological process and cellular 
component. Each ontology is represented as directed acyclic graphs (OAG) where each 
node can have one or more parents and zero or more children. There are two types of 
associations, is a, which means the child is a subclass of the parent; and part of 
indicating the child is a component of the parent [The Gene Ontology Consortium, 2001; 
Gene Ontology Consortium, 2006]. 
Gene ontology annotations can also be used to determine which protein homologous 
sets are involved in the same biological process and have the same molecular functions. 
According to Groenen et al. [ 2006] sets of proteins were said to be active in the same 
process if they shared a 4th level element of the GO biological process tree, in which the 
root is the first level element and every succeeding branch is one level higher. GO 
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be used as a source of validating functional similarity between gene products generated 
from sequence similarity methods [Calamita et a/., 2005] 
GO SLIM - GO Slims (GS) are summarized versions of the GO vocabulary. A GS 
contains a division of the terms in the whole GO that give a general idea of the ontology 
content without the detail of the specific terms. GS mainly functions to generate a 
summary of the results of GO annotation of a gene when wide classification of gene 
products function is required [http://www.geneontology.org/GO.slims.shtml]. Since each 
protein from different organisms could be annotated to different levels of the GO 
hierarchy, we decided to use GS to more easily compare the functional annotations 
within a cluster. We utilized the Integr8 GOSLIM file for each genome which is a set of 
high-level terms selected to cover major aspects of each of the three GO ontologies 
without overlapping in paths of the GO hierarchy [Biswas et a/., 2002]. 
4.3 Methods 
4.3.1 Functional Information 
We downloaded InterPro matches for all 84 proteomes from the Integr8 Proteome 
Analysis Database. We also obtained complete GO Slim data for each of the selected 
genomes in this study [htttp://www.ebLac.uk/integr8]. 
4.3.2 Creating Database for Gene Sequences and Functional Information 
A MySOL database was created to store all the results from this project. The data stored 
in the database is outlined below. 
Protein Sequence information - 246573 protein sequences from the 84 complete 
genomes together with their, standardized names/description (DE) lines, accession 
numbers and organism codes (OS codes) were extracted, and loaded into the MySOL 
database. 
InterPro methods table - the InterPro signature methods, matches for each domain 
(start and stop positions), and corresponding protein accession numbers were extracted 
and added to the database. 
Gene ontology and GO slim - GO identifiers (GOid); GO ontology (one of the three -
biological process (P), molecular function (F) and cellular component (C)); evidence 
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slim name were retrieved from Integr8 GO files for each proteome and maintained in the 
database. 
BLAST output table- the BLASTP output was parsed to generate a BLAST table in the 
database representing each query sequence accession number and all the resulting hit 
protein accession numbers, organism codes (OS code), expected values, bit scores, 
percentage length coverage, and percentage sequence identities across all 84 genomes. 
Cluster output table - the clustering outputs from the BLASTP clustering method, and 
BLASTClust 0.5 and 1.0 were added to the protein sequence information table to create 
linkages between each protein accession number and all other data in the database to 
each clustering experiment. 
4.3.3 Analysis of functional conservation within clustering experiments 
Conservation of functions were examined by using various Sal queries to count unique 
InterPro ids and GO Slim ids (by ontology) in each cluster and python scripts were 
written to generate the percentage of these functional labels present in each cluster for 
each clustering experiment. The protein description lines (DE line) were also examined 
for conservation of terms. Since counting unique DE lines was difficult due to major 
differences in naming of protein sequences, this was not used further for the analysis. 
4.3.4 Selection of pathogen and MTB specific clusters 
For each BlASTClust experiment, all the clusters that were pathogen-specific and 
contained a representative from MTB, were selected as potential virulence gene clusters 
for further functional investigation. These are referred to as the 'predicted' clusters. 
Those clusters that contain MTB but were not pathogen-specific were regarded as not 
predicted MTB clusters. 
4.3.5 Functional analysis of predicted virulence gene clusters 
The protein DE lines were examined for the two sets above to investigate those that had 
been assigned a function and those annotated as hypothetical proteins. A set of 
functional categories (13 high-level function terms) was generated and a single category 
applied to each M. tuberculosis CDC1551 protein based on the DE line. The categories 
included: unknown, cell cycle, DNNRNNprotein metabolism, enzyme, ESAT, foreign 
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response, surface (membrane and secreted proteins) and virulence. The functional 
composition of both predicted and not predicted MTS clusters was determined using 
these functional categories. The results were summarized in charts. 
In addition to the functional analysis above, a statistical analysis was done to compare 
the predicted and non-predicted protein sets and determine whether any GO terms were 
significantly over-represented in the predicted set. For this we used the Ontologizer tool 
[Robinson et a/., .2006] and the GO annotations for each MTS (CDC 1551) protein, 
where available. Ontologizer takes as input a set of selected protein accessions (study) 
and the reference set (population), as well as gene association files for the organism. It 
performs a modification of the Fischer's Exact test and uses the Sonferroni correction to 
correct for multiple testing. The program takes into account parent-child relationships in 
GO terms, and thus considers the structure of the hierarchy, which is supposed to 
produce fewer false positive results. 
4.3.6 Analysis of hypothetical proteins 
For the hypothetical proteins in the predicted virulence set the InterPro matches were 
downloaded and examined to see whether we could assign a potential function based on 
the protein family and domain hits. We also investigated some clusters that contain 
hypothetical proteins to check if the predicted functions are conserved among the 
members of hypothetical proteins in same cluster based on their InterPro matches. 
4.4 Results and Discussions 
4.4.1 Functional conservation 
InterPro and GO annotation data capture the available functional information of a gene 
product and can be used as a source for assessing functional similarity between gene 
products in each cluster. Figures 4.1 and 4.2 show the existence and conservation of 
InterPro and GO annotations of proteins that exist in each cluster in the two experiments. 
The percentage of proteins with InterPro matches, ranges from 75 to 100% in 0.5S and 
75 to 97% in 1.0S. In total, InterPro annotations cover above 70% of all available 
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It is observed in our result that the number of proteins in each cluster that have GO term 
annotation is very low compared to InterPro annotations. This ranges from as low as 3 
proteins in a cluster of over 200 proteins (0.013%) to a high of 50% in 0.58 and 0.011 % 
to 80% in 1.08 experiments. This is due to the fact that a large number of gene products 
are not yet annotated with GO terms as was observed by Andreas et al. [2006]. 
Regarding conservation, a very good correlation was observed, with the majority of the 
member proteins having similar description lines and the same InterPro identity. At least 
60% and 92% of protein members of every cluster in 0.58 and 1.08 respectively are 
annotated to same InterPro and GO slim term, where available. However the annotations 
are more conserved in 1.08 with over 90% of the members mapping to the same 
InterPro families. 
4.4.2 Selection of pathogen and MTB specific clusters 
Experimentally we predicted about 8000 and 18000 pathogen specific clusters for 0.5 
and 1.08 respectively. Out of these figures, 1015 and 2355 clusters, respectively, 
contain potential virulence MTS genes due to their being predicted as pathogen-specific 
clusters with MTS gene members. These numbers are portions of the pathogen specific 
clusters that have MTS complex organisms generally 
The whole M. tuberculosis CDC1551 proteome (the reference virulence MTS complex 
organism) contains over 4000 proteins. Of the 4172 proteins (that is, the number of 
proteins of the reference organism predicted as member of the above number clusters), 
1167 in 0.58 and 2614 in 1.08 were members of predicted pathogen-specific clusters 
and the rest are members of non pathogen-specific clusters. From our result it can be 
noted that 1.08, which is the most stringent experiment, predicted more potential 
virulence MTS genes with close to 65% of the whole M. tuberculosis CDC1551 proteome 
being a member of predicted virulence gene clusters (that is, either unique to MTS 
complex organisms or MTS and other pathogens). 
The 0.58 experiment, on the other hand, only predicted about 29% of the whole 
CDC1551 proteome to be members of potential virulence gene clusters. This is due to 
the fact that some of these families of genes that are predicted in the 1.08 experiment as 
virulence gene clusters are included in non-predicted families of genes in 0.58, due to 
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the latter data set. For example, the PE/PGRS family includes 2 non pathogenic 
actinomycetes in the 0.5S experiment. 
When looking more closely at some of the clusters from the two experiments, the 1.0S 
results better reflect what has previously been reported. For example, the PE/PPE family 
has been reported to be unique to MTB organisms [Gey van Pittius et al., 2006], and 
0.5S identifies some cluster members in other organisms and is probably therefore not 
strict enough. Gey van Pittius et al. report that some similarity has been found to proteins 
in other closely related organisms, but this is due to non-specific alignment of repeated 
regions, and these other proteins do not contain the conserved PE/PPE domains and 
motifs. The 1.0S results are still, however, quite surprising in the high number of 
proteins not found in non-pathogenic organisms. There are relatively few proteins 
conserved across all pathogens and not found in non-pathogens, and the results also 
indicate a high proportion of MTB complex-specific proteins. 
4.4.3 Functional Analysis of the M. tuberculosis proteome in predicted and not 
predicted pathogen specific clusters 
Figures 4.3 and 4.4 compare the functional composition of both predicted and not 
predicted potential virulence MTB gene sets for each experiment, BLASTClusto.5 and 
1.0. 
In the 0.5S results, the cases where the number of proteins in the predicted set exceeds 
that in the not-predicted set are the "Antigens,"ESA T" and "surface" categories, the latter 
of which includes membrane and secreted proteins. This is probably a result of the fact 
that the not-predicted set is bigger for all other categories. For the 1.0S results, the 
bigger set now includes all the PE/PPE proteins, and a significant proportion of the 
unknown, surface, antigen and virulence proteins, which may all playa role in virulence 
or the intracellular lifestyle of the organism as predicted compared to non predicted sets. 
Of particular interest are the proteins that are characterized as unknown or hypothetical 
proteins, which occupy the highest percentage in both predicted and not predicted gene 
sets in both of the experiments. For 0.5S, 63% of the total predicted virulence genes are 
unknown (Figure 4.5a) and 35% of the total not predicted genes are unknown (Figure 
4.5b). The percentage of unknown proteins in the 1.0S predicted and not predicted sets 
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Also apparent is the distribution of enzymes and the PE/PPE families of protein in the 
experiments. For the predicted virulence gene set, the enzyme set only occupied about 
10% of all proteins in 0.58 and 23% in 1.08, while the proportion of proteins that are 
annotated as enzymes are similar in both experiments for the not predicted set. Unlike 
the other functional categories, the percentage of PE/PPE proteins in the predicted 
virulence gene set is almost 6 times bigger in 1.08 experiment compared to 0.58. 
On the other hand, the 0.58 experiment produced a larger proportion of PE/PPE proteins 
in the not predicted sets. This is a result of the 0.58 experiment being more lenient than 
1.08 for inclusion of members. It was previously observed that most members of these 
families form a cluster with some related non pathogenic actenomyces organisms as 
discussed above. 
In contrast to our expectations, the fraction of the proteome that is functionally annotated 
as being involved in virulence is very low, only 1 and 1.4% of the predicted virulence set 
in 0.5 and 1.0s respectively. However, this reflects the current low level of knowledge 
about which genes are involved in virulence in this organism. The number of 
characterized virulence genes in the predicted set is significantly higher than the not 
predicted set for the 1.08 experiment. 
We also examined the functions that are over-represented in MTB proteins that have 
been predicted as potentially virulent using GO annotations and the Ontologizer software 
[Robinson et al., 2006]. Using Ontologizer, we performed a statistical analysis to 
determine which GO terms were overrepresented in the predicted sets to see whether 
certain functions were unique to this organism and pathogens, and further confirm 
whether those gene sets are involved in pathogenesis and virulence of the organism. 
However it must be noted that this analysis was carried out for only part of the data set 
that has GO annotation. 
Figure 4.7 shows a summary of GO terms that are Significantly overrepresented in the 
predicted virulence set compared to all proteins in the genome for the 1.08 experiment. 
The terms that are over-represented are shaded in three different colours based on the 
three GO ontologies. The terms shown are those with a p-value of less than E-5. Other 
terms that are positioned between the significant terms and the root term are shown with 
no shading. These GO terms, as well as additional GO terms with a p value of less than 
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Figure 4.7: Summary of the significantly overrepresented GO terms in the 
predicted set for 1.0S 
The result of our GO analysis revealed that a number of terms related to the membrane 
and membrane components were significantl y overrepresented in the ce llular component 
ontology, and protein kinase activity was prominent among the molecular function 
annotations of the predicted set. Interest ingly, pathogenesis and multi·organism process 
were also the most significant bio log ical processes shown to be overrepresented in the 
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Table 4.1: Significantly «E -4) over-represented GO terms in predicted set from the 
1.0S experiment. 
GOlD GO name P value 
GO:0006468 protein amino acid phosphorylation 1.246 E-4 
GO:0043687 post-translational protein modification 8.124 E-4 
GO:0009187 cyclic nucleotide metabolic process 7.969 E-4 
GO:0051704 multi-organism process 6.642 E-5 
GO:0007242 intracellular signaling cascade 4.385 E-4 
GO:0044419 interspecies interaction between organisms 1.157 E-4 
GO:0009405 pathogenesis 1.207 E-5 
GO:0044403 symbiosis, encompassing mutualism through parasitism 1.156 E-4 
GO:0004497 monooxygenase activity 4.710 E-4 
GO:0004672 protein kinase activity 3.8083 E-5 
GO:0003700 transcription factor activity 5.837 E-4 
GO:0044425 membrane part 3.459 E-19 
GO:0016021 integral to membrane 3.459 E-19 
GO:0016020 Membrane 1.022 E-17 
GO:0031224 intrinsic to membrane 3.459 E-19 
The 0.5S results had fewer overrepresented GO terms in the predicted set, and these 
included terms such as membrane, integral to membrane, regulation of transcription and 
DNA binding. 
It is difficult to draw too many conclusions from the data because of all the proteins that 
do not have GO annotations. However, the appearance of the above GO terms in the 
summary of significantly overrepresented GO annotations results suggested that many 
of the proteins in the predicted set are membrane proteins that are involved in 
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4.4.4 Analysis of hypothetical proteins 
Approximately 40% of the MTB genome is made up of hypothetical proteins or proteins 
of unknown function. Since many of the predicted protein sets are hypotheticals, we tried 
to predict functions for some of them. Table 4.2 shows some of the proteins in the 1.OS 
experiment predicted set that have been classified as unknown, together with their 
InterPro matches. We observed that some of these groups can be assigned potential 
functions based on InterPro matches, which could serve as the basis for further 
investigation of some interesting clusters. Most of these proteins appear to be enzymes, 
but some are involved in transcription regulation, and some in prevent-host-death and 
abortive infection, which could be involved in the pathogenesis processes of the 
organism. To compare InterPro matches of some of the interesting clusters of 
hypothetical proteins we selected 3 clusters from the 1.OS experiment"based on the fact 
that all the hypothetical members of these clusters hit the same InterPro domains and 
some have predicted structures that can be modelled. The above characteristics make 
them good examples of hypothetical gene clusters that can be further investigated and 
removed from the list of hypothetical proteins. 
Figure 4.8a shows the protein matches for the first cluster tested, that contained 11 
hypothetical proteins. In this cluster all the members hit an O-methyltransferase domain, 
and we also observed that members of this cluster have a predicted structure that can be 
modeled base on a known protein databank (PDB) structure, 1 rjd. The PDB structure is 
for a carboxy methyl transferase protein that is involved in regulating protein 
phosphatase 2a activity. 
It is observed that the next cluster seems to contain a nuclease domain that may be 
involved in transposition as shown in Figure 4.8b, while the last cluster include proteins 
that are guany/y/ cyc/ases with a histidine kinase domain. This domain is predicted to be 
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Table 4.2: Proteins in 1.08 predicted set that are previously classified as unknown and their InterPro matches. 
Protein Accession InterPro 10 InterPro Name 
005294 IPR008262 Lipase, active site 
005305 IPR003593 AAA+ ATPase, core 
005305 IPR011990 Tetratricopeptide-like helical 
005309 IPR001173 Glycosyl transferase, family 2 
005460 IPROO0641 CbxXICfqX 
005573 IPR013974 SAF domain 
005592 IPR013781 Glycoside hydrolase, catalytic core 
005770 IPR002641 Patatin 
005815 IPR009078 Ferritin/ribonucleotide reductase-like 
005854 IPR011047 Quinonprotein alcohol dehydrogenase-like 
005856 IPR002197 Helix-turn-helix, Fis-type 
005866 IPR009187 Predicted Ku, prokaryotic type 
005882 IPR006037 TrkA-C 
005918 IPROO0846 Dihydrodipicolinate reductase 
006178 IPR003736 Phenylacetic acid degradation-related protein 
006178 IPR006683 Thioesterase superfamily 
006218 IPR003779 Carboxymuconolactone decarboxylase 
006218 IPR004675 Alkylhydroperoxidase AhpD core 
006232 IPROO0836 Phosphoribosyltransferase 
006233 IPR007712 Plasmid stabilization system 
006242 IPROO0403 Phosphatidylinositol 3- and 4-kinase, catalytic 
006242 IPROO0601 PKD 
006250 IPROO0631 Carbohydrate kinase 
006288 IPR002502 N-acetylmuramoyl-L-alanine amidase, family 2 
006328 IPR011251 Bacterialluciferase-like 
006351 IPR005149 Transcriptional regulator PadR-like 
006351 IPR011991 Winged helix repressor DNA-binding 
006412 IPR004360 Glyoxalase/bleomycin resistance /dioxygenase 
006415 IPR002716 PiiT protein, N-terminal 
006547 IPR013217 Methyltransferase type 12 
006572 IPR001054 Adenylyl cyclase class-3/4/guanylyl cyclase 
006580 IPR003615 HNH nuclease 
006580 IPR013324 Sigma factor, regions 3 and 4 
006592 IPR004378 Mycobacterium tuberculosis paralogous family 11 
006619 IPR009097 Appr>p cyclic nucleotide phosphodiesterase 
006630 IPR003675 Abortive infection protein 
006630 IPROOO015 Fimbrial biogenesis outer membrane usher protein 
006632 IPROO0182 GCN5-related N-acetyltransferase 
006780 IPR003477 PemK-like protein 
006780 IPR011067 Plasmid maintenance toxin/Cell growth inhibitor 
006800 IPR003779 Carboxymuconolactone decarboxylase 
006800 IPR004675 Alkylhydroperoxidase AhpD core 
007187 IPROO0802 Arsenical pump membrane protein 
007187 IPR004680 Citrate transporter 
007205 IPR013813 YjgF/chorismate mutase-like 
007205 IPR006175 Endoribonuclease L-PSP 
007238 IPR001854 Ribosomal protein L29 
007239 IPR001023 Heat shock protein Hsp70 
007251 IPR013216 Methyltransferase type 11 
007429 IPR006025 Peptidase M, neutral zinc metallopeptidases 
007733 IPR002589 Appr-1-p processing 
007738 IPR004136 2-nitropropane dioxygenase, NPD 
007742 IPR007372 Ycel 
007743 IPR003455 O-methyltransferase, N-terminal 
007751 IPR006992 Amidohydrolase 2 
007754 IPR012349 Pyridoxamine 5-phosphate oxidase, FMN-binding 
007764 IPR004027 SEC-C motif 
007764 IPR011990 Tetratricopeptide-like helical 
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Table 4.2 contd. 
Protein Accession InterPro 10 InterPro Name 
007782 IPROO6442 Prevent-host-death protein 
007810 IPROO0150 Cof protein 
007810 IPR006379 HAD-superfamily hydrolase, subfamily liB 
007810 IPR005834 Haloacid dehalogenase-like hydrolase 
033195 IPROOO577 Carbohydrate kinase, FGGY 
033239 IPR011101 Phage Gp37Gp68 
033266 IPR002711 HNH endonuclease 
033302 IPR011660 Rv0623-like transcription factor 
050380 IPR012951 Berberine/berberine-like 
050389 IPROO0253 Forkhead-associated 
050389 IPR008984 SMAD/FHA 
08VKS1 IPROO0477 RNA-directed DNA polymerase (Reverse transcriptase) 
08VK08 IPR005031 Streptomyces cyclase/dehydrase 
07D9C8 IPR010093 Excisionase/Xis, DNA-binding 
07D9D6 IPR003455 O-methyltransferase, N-terminal 
07D9HO IPR003675 Abortive infection protein 
07D964 IPR005467 Histidine kinase 
07D967 IPR011701 Major facilitator superfamily MFS_1 
07D980 IPR001647 Bacterial regulatory protein, TetR 
07D980 IPR009057 Homeodomain-like 
07D9HO IPR003675 Abortive infection protein 
07D9X9 IPR010419 Carbon monoxide dehydrogenase subunit G 
07D9T2 IPROO1104 3-oxo-5-alpha-steroid 4-dehydrogenase, C-terminal 
07D9L2 IPROO0318 Nitrogenase component 1 alpha and beta subunits 
07D9M2 IPR002925 Dienelactone hydrolase 
07D8W2 IPR001087 Lipolytic enzyme, G-D-S-L 
07D8W2 IPR013831 Esterase, SGNH hydrolase-type, subgroup 
07D8PO IPR013228 PE-PPE, C-terminal 
07D708 IPR011067 Plasmid maintenance toxin/Cell growth inhibitor 
06ARF7 IPR008975 Viral coat and capsid protein 
050593 IPROO0644 Cystath ion i ne-beta-synthase 
011037 IPR012338 Penicillin-binding protein, transpeptidase fold 
011034 IPR013656 PAS fold-4 
011034 IPR010822 Sporulation stage II, protein E C-terminal 
010880 IPR001750 NADH/Ubiquinone/plastoquinone (complex I) 
P96936 IPR004147 ABC-1 
010384 IPR006055 Exonuclease 
P96916 IPROO6442 Prevent-host-death protein 
P95041 IPR003785 Creatininase 
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4.5 Conclusions 
In summary. from the results of this chapter we observed a very good correlalion of 
functional informati()fl within member proteins of each cluster, with the majorily of the 
same cluster proteins having similar description lines and identical InterPro and GO 
annotations, where available. However. It shoukJ be roted that cOrlctusions based ()fl GO 
arlnotations should be considered With cautoon. due to the nature of the annota ll()fls, 
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sequence similarity. The InterPro and GO annotations were more conserved in 1.0S with 
over 90% of the members mapping to the same InterPro families and GO annotations. 
The functional analysis and statistical results of GO term annotations for the predicted 
set suggested that many of these proteins are involved in pathogenesis of 
Mycobacterium tuberculosis (the reference genome), with some being part of the 
PE/PPE family, known virulence proteins, or membrane-associated or secreted proteins. 
While some of the predicted proteins, that is, those unique to MTB or to pathogens, may 
not be related to pathogenesis, the concentration of potential virulence-related genes in 
the predicted set suggests that there may be many more genes in this set that could play 
a role in virulence in MTB. We need to look further at some of the hypothetical proteins, 
particularly, to determine whether they have a role in the pathogenic lifestyle of the 
organism. 
Unsurprisingly, most of the experimentally predicted potential virulence gene sets are 
hypothetical proteins. This is expected, since annotation is done based on homology with 
other proteins in the database, and those that have no hits in other organisms can only 
initially be annotated as hypothetical. Some may have hits in other organisms (for 
instance, other pathogens), but the hits may have been to hypothetical proteins. Based 












Comparative Evolutionary Analysis 
While the pathogenesis and epidemiologies of tuberculosis are well studies, 
relatively little is known about the evolution of the infectious agent 
Mycobacterium tuberculosis, especially at the within-host leveL .. 
-Tanaka, 2004 
This chapter aims to understand the evolutionary diversity within selected homolog sets 
including those that contain candidate virulence genes of Mycobacterium tuberculosis. It 
also investigates the evolutionary processes or mechanisms producing such changes. It 
addresses the objectives by answering the following questions: 
• What is the rate of non-synonymous to synonymous substitutions within the selected 
homologue sets? 
• What is the phylogenetic distance between sequences of the selected sets? 
• What is the measure of selective pressure acting on the members of the sets? 
• How are the above estimated parameters likely to affect functions and structures of 
the members of the set? 
5.1 Overview 
In this chapter we investigate some predicted clusters of interest with characterized 
proteins to determine how these genes evolved. This was achieved via analysis of the 
evolutionary changes to determine functional and structural constraints and distance 
between the sequences within the clusters. Some of the clusters investigated were 
predicted in chapter three to have cellular roles in virulence in pathogens. 
We also investigated duplicate copies of proteins in mycobacterial species in these 
clusters to determine whether expansion of these families of genes is linked with the 
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5.2 Background 
Sequence homology is used to refer to nucleotide or protein sequences that share a 
common ancestor [Hillis, 1994; de Pinna, 1991]. Homologous sequences can be 
classified into orthologous and paralogous sequences. Orthologous sequences are 
formed from a speciation event [Hills, 1994; Patterson, 1988] and become very useful for 
inferring evolutionary relationships among genes for phylogenetic studies [Filliol et al., 
2006]. Paralogous sequences on the other hand occur as a result of a gene duplication 
event [Fitch, 1970; Groenen, 1993; Fitch, 2000; Patterson, 1988]. Paralogous genes are 
used to study the history of gene duplication [Hillis, 1994]. 
The evolutionary relationships between DNA or protein sequences from organisms within 
and between species can be inferred from the amount of genetic variation found in the 
different genomes as a result of different types of mutations [Frothingham, 1995]. 
Sequence polymorphisms and gene duplications are an important source of genetic 
variation between organisms [Dufayard et al., 2005]. They are also important in 
acquisition of genes that are essential for adaptability of organisms to their environment 
[Alland et al., 2007]. For instance, some duplication and mutation processes provide 
pathogens with a selective advantage to invade the host immune system [Sekiguchi, 
2007; Musser, 1995]. 
After speciation or duplication events, homologous sequences diverge from each other 
as different mutations occur in the individual sequences [Zmasek and Eddy, 2001]. 
Depending on the rate of mutation and the selection pressure acting on homologous 
sequences, certain types of mutations can result in the creation of new functions [Jothi et 
al., 2006]. Mutations are alterations that occur in DNA sequences due to the change in 
and deletion of bases; insertions; inversions and substitutions [den Dunnen and 
Antonarakis, 1999] and can involve a single DNA base pair or a large segment of a 
chromosome [Cardoso et al., 2004]. Substitutions involve the change of one nucleotide 
to another [Karboul et al., 2006], that is, a point mutation or single nucleotide 
polymorphism, and can be divided into transversions and transitions. 
A transversion is the mutation from a purine to a pyrimidine or vice versa, while a 
transition is the substitution from a pyrimidine to a pyrimidine or purine to a purine [Jothi 
et al., 2006]. A substitution that leads to no amino acid change is called a synonymous 
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amino acid replacement substitution is referred to as a non-synonymous substitution and 
often results in a change in the function of the protein [Karboul et a/., 2006; Nei and 
Gorjobori, 1986]. 
In order to infer equivalence in gene functionality or maintain gene function within a 
species, the number of non-synonymous substitutions (dN) should therefore remain 
small. In most cases the number of synonymous substitutions (dS) does not affect the 
functionality of the gene [Kimural, 1983]. The ratio dN/dS (r ' gamma) provide a measure 
of the selective force or constraints on the genes or genomes being studied. A gamma 
value less than 1 (r <1) indicates purifying selection with a value of 1 (r =1) implying 
neutral evolution. A gamma value greater than one (r > 1) means diversifying selection. 
When gamma is significantly greater than one, positive selection can thus be inferred 
[Yang et a/., 2002]. This indicates less functional or structural constraints in the 
population or set of genes being tested. For example orthologous or paralogous sets of 
genes with a gamma ratio greater than one may likely not share the same function. On 
the other hand, since purifying selection is a sign of high functional or structural 
maintenance or conservation within the group or population, with a gamma value of less 
than one there is a high possibility of homologous proteins having the same function. 
5.3 Material and Methods 
Amino acid coding DNA sequences for each protein accession number in different 
experimentally predicted virulence clusters were downloaded from the Sequence 
Retrieval System (SRS) searching the EMBL database at httpJ/srs.ebi.ac.uk/srsbin/ . 
Pair-wise and multiple DNA sequence alignments were performed using the ClustalW 
package of BioEdit. For each aligned set of sequences the following analyses were 
performed: 
• Pair-wise, within group synonymous and non synonymous single nucleotide 
substitutions calculated, and DNA polymorphism and divergence between 
phylogenetic lineages determined using the DNA Sequence Polymorphism package, 
DNASp 4.10 [Rozas et a/., 2003]. 
• Investigated nature of mutations between members of each cluster by conducting a 
neutrality test using equations proposed by McDonald and Kreitman [1991] with the 
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• Estimated evolutionary distance and proportion of amino acid differences between 
the sequences; drew a Bootstrap neighbor-joining tree using the neighbor-joining 
algorithm with the Molecular Evolutionary genetics Analysis (MEGA3.1) package 
[Kumar et a/., 2004]. 
5.4 Results and Discussion 
5.4.1 Multiple sequence alignments 
Pair-wise comparative sequence analysis using ClustalW shows that the amino acid 
sequences within each cluster are highly similar to each other (Figures 5.1, 5.2 and 5.3). 
Identical amino acid residues are shown in the alignments with black shading. There are 
many sites (prolog sites) with a high density of identical amino acid residues (more than 
10 residues and a few variable bases followed by other highly identical residues). These 
conserved terminals or domains are likely to be important for function or conservation of 
structural folds for genes that are within the same family. 
5.4.2 Nucleotide diversity and polymorphic divergence 
The pattern of synonymous and non synonymous substitutions can provide information 
about mutations and selective forces on genes as well as information about the 
population and recombination events [Fleishmann et aI, 2002]. We investigated gene 
members of two clusters that contain MTB complex organisms as well as other 
phylogenetic lineages, and one MTB complex-specific cluster. This was to check 
whether there was any evolutionary constraint that might be acting on the synonymous 
and non synonymous substitutions that might affect the function or structure of members 
of the cluster. 
The number of synonymous nucleotide substitutions per synonymous site, dS, and the 
number of non-synonymous nucleotide substitutions per non-synonymous site, dN, for 
each cluster were investigated according to Nei and Gojobori [1986]. Tables 5.1 a to 5.1 c 
show the pair-wise nucleotide diversity and dS , dN while Tables 5.2a to 5.2c reveal the 
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Table 5.1a: Pair-wise comparison of synonymous and non-synonymous substitutions within the bi-
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Table 5.1 b: Pair-wise comparison of synonymous and non-synonymous substitutions within the 
Deoxyribose-phosphate aldolase protein cluster. 
Seq 1 Seq 2 SynDif NSynDif SynPos NSynPos dS dN dNldS 
CAE48777(CORDI CAD93351 (MYCBO) 117.33 141.67 173.17 471.83 0.3835 1.7531 0.21876 
CAE48777(CORDI CAC31968(MYCLE) 123.83 146.17 173.58 471.42 0.4001 2.2649 0.17665 
CAE48777(CORDI CAB00939(MYCLEH) 117.33 141.67 173.17 471.83 0.3835 1.7531 0.218756 
CAE48777(CORDI AAK44 719(MYCTU) 117.33 141.67 173.17 471.83 0.3835 1.7531 0.218756 
CAE48777(CORDI AAS06521 (MYCPA) 113.17 135.83 176 469 0.366 1.4604 0.25062 
CAE48777(CORDI AAT83758(PROAC) 114.67 134.33 166.67 478.33 0.3518 1.8697 0.18816 
CAD93351 (MYCBO CAC31968(MYCLE) 81 56 180.42 464.58 0.1314 0.6846 0.19194 
CAD93351 (MYCBO CAB00939(MYCLEH) 0 0 180 465 0 0 0 
CAD93351 (MYCBO AAK44719(MYCTU) 0 0 180 465 0 0 0 
CAD93351 (MYCBO AAS06521 (MYCPA) 87.67 48.33 182.83 462.17 0.1126 0.7648 0.14723 
CAD93351 (MYCBO AA T83758(PROAC) 101.75 157.25 173.5 471.5 0.4412 1.1422 0.38627 
CAC31968(MYCLE CAB00939(MYCLEH) 81 56 180.42 464.58 0.1314 0.6846 0.19194 
CAC31968(MYCLE AAK44719(MYCTU) 81 56 180.42 464.58 0.1314 0.6846 0.19194 
CAC31968(MYCLE AAS06521 (MYCPA) 102 57 183.25 461.75 0.1349 1.0165 0.13271 
CAC31968(MYCLE AAT83758(PROAC) 118.42 159.58 173.92 471.08 0.4507 1.7882 0.25204 
CAB00939(MYCLEH AAK44 719(MYCTU) 0 0 180 465 0 0 0 
CAB00939(MYCLEH AAS06521 (MYCPA) 87.67 48.33 182.83 462.17 0.1126 0.7648 0.14723 
CAB00939(MYCLEH AA T83758(PROAC) 101.75 157.25 173.5 471.5 0.4412 1.1422 0.38627 
AAK44719(MYCTU AAS06521 (MYCPA) 87.67 48.33 182.83 462.17 0.1126 0.7648 0.14723 
AAK44719(MYCTU AAT83758(PROAC) 101.75 157.25 173.5 471.5 0.4412 1.1422 0.38627 
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Table S.1c: Pair-wise comparison of synonymous and non-synonymous substitutions within the MTB complex virulence 
factor MCE protein cluster. 




































AAK44401 (MYCTU) AAK44846(MYCTU) 













































































































1067.67 1.1738 0.2473 0.210683 
1072.25 1.1921 0.1370 0.114923 
1071.17 0 0 0000000 
1067.25 1.1401 0.2325 0.203929 
1066.25 0.8149 0.1206 0.147994 
1063.25 0.9701 0.2520 0.259767 
1071.17 0 0 0.000000 
1067.25 1.1401 0.2325 0.203929 
1068.75 1.1521 0.2699 0.234268 
1067.67 1.1738 0.2473 0.210683 
1063.75 0.0257 0.0186 0.723735 
1062.75 0.7916 0.2607 0.329333 
1059.75 0.6675 0.1241 0.185918 
1067.67 1.1738 0.2473 0.210683 
1063.75 0.0257 0.0186 0.723735 
1072.25 1.1921 0.1370 0.114923 
1068.33 1.1113 0.2529 0.227571 
1067.33 0.9023 0.1033 0.114485 
1064.33 1.0035 0.2967 0.295665 
1072.25 1.1921 0.1370 0.114923 
1068.33 1.1113 0.2529 0.227571 
106725 1.1401 0.2325 0.203929 
1066.25 0.8149 0.1206 0.147994 
1063.25 0.9701 0.2520 0.259767 
1071.17 0 0 0.000000 
1067.25 1.1401 0.2325 0.203929 
1062.33 0.7805 0.2440 0.312620 
1059.33 0.6436 0 1083 0.168272 
1067.25 1.1401 0.2325 0.203929 
1063.33 0 0 0.000000 
1058.33 0.4982 0.2757 0.553392 
1066.25 0.8149 0.1206 0.147994 
1062.33 0.7805 0.2440 0.312620 
1063.25 0.9701 0.2520 0.259767 
1059.33 0.6436 0.1083 0.168272 
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Table 5.2a: Nucleotide diversity of the beta-proteobacterial and MTB complex genes. 
Number of Number of 
Type of site sites substitutions 
BORPA 
Synonymous 403.33 235 
Nonsynonymous 1180.67 268 
BORPE 
Synonymous 408.92 156 
Nonsynonymous 1199.08 143 
MTB COMPLEX 
Synonymous 396.58 218 
Nonsynonymous 1142.42 117 
BRUMA 
Synonymous none none 
Nonsynonymous none none 
Within species 
diversity 














This seems to indicate a decreased selective pressure against synonymous 
substitutions, or purifying selective pressure for the MTB complex genes. There is also a 
higher evolutionary pressure on non-synonymous substitutions per non-synonymous site 
( dN) for the proteobacteria and high-GC organisms than for MTB complex members of 
the same cluster. This low frequency of mutations in M. tuberculosis genes compared to 
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Table 5.2b: Nucleotide diversity of the high-GC and MTB complex genes. 
Type of site Number of Number of Within species dNldS 
Sites substitutions diversity(dS or dN) 
High GC bacterial 
Synonymous 168.83 131 1.90712 
Nonsynonymous 488.17 122 0.34935 0.183182 
Mycobacterial complex 
Synonymous 188.43 143 0.54712 
Nonsynonymous 480.57 61 0.08781 0.160495 
Table 5.2c: Nucleotide diversity of the MTB complex MCE genes 
Type of site Number of Number of substitutions Within species diversity dNldS 
Sites (dS or dN) 
MYCTU 
Synonymous 395.58 231.75 1.139 
Nonsynonymous 1131.42 246.25 0.257 0.22562 
MYCTU2 
Synonymous 395.58 231.75 1.139 
Nonsynonymous 1131.42 246.25 0.257 0.22562 
MYCBO 
Synonymous 
406.5 247.75 1.256 
Nonsynonymous 1174.5 147.25 0.137 0.10923 
MYCLE 
Synonymous none none none 
Nonsynonymous none none none na 
MYCPA 
Synonymous 395.67 147.42 0.515 
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Looking more specifically at the different protein clusters, the dN I dS values for the bi-
functional Gamma-glutamyltransferase (GGTA) protein cluster signify that the beta-
proteobacterial copies of the gene seem to have greater diversity than the MTB complex 
genes (Table 5.2a), whereas the dN I dS values for High-GC and MTB complex 
organisms are much closer for the Deoxyribose-phosphate aldolase protein cluster 
(Table 5.2b). For the latter cluster the similarity in the values is a result of a combination 
of a much higher rate of synonymous substitutions in the High-GC organism gene and 
the much lower rate of non-synonymous substitutions in the MTB complex genes. 
The different observations for the 2 clusters could be due to the fact that in the first 
cluster, the beta-proteobacteria copies contain paralogs from same species while MTB 
complex and high-GC members of same family (second cluster) contain one copy of the 
gene per species. It could therefore be possible that the duplicated copy of the gene may 
be losing functionality within the species. There are hypotheses of evolutionary scenarios 
where paralogs either acquire a new function that is different to the original function or 
where the paralogous copies share the function of the original protein [Nembaware et. 
a/., 2002]. 
Investigation of the dN I dS values for the virulence factor MCE protein family (MCE1 D), 
containing MTB complex-specific genes shows that the dN I dS values are almost equal 
among different species of MTB complex organisms with the exception of 
Mycobacterium avium paratuberculosis having higher dN I dS values close to 0.6. 
Interestingly, all the members of the cluster have two copies of this gene except 
Mycobacterium leprae with only one copy (Table 5.1 c). This could imply that more than 
one copy of this gene is important for increased virulence of the species or that one copy 
of these genes was lost in Mycobacterium leprae due to reductive evolution. This is 
consistent with the findings of Cole et al. [2001]. 
Comparative sequence analysis of M. leprae and M. tuberculosis provided evidence for 
reductive evolution in M. leprae. Many of the genes being lost in M. leprae tend to 
become pseudogenes or are inactivated as their functions are no longer required in 
highly specific niches [Cole et al., 2001]. 
It is evident from the dN I dS ratios for the paralogous MTB complex genes that these 
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selection is acting on the genes. The values observed for the MTB complex specific 
cluster are close to what is observed in other clusters that are shared between MTB 
complex and other phylogenetic lineages. 
The trends observed above could be due to the different evolutionary constraints that 
affect MTB complex organisms compared to other bacteria. This is in agreement with 
previous work that reported the ratio of non-synonymous substitutions to synonymous 
substitutions to be silent and much lower than 1.0 among MTB complex organisms 
compared to an average ratio close to 1 that is generally observed among other bacterial 
species [Scorpio and Zhang, 1996]. 
5.4.3 Polymorphic divergence 
Polymorphic divergence is a measure of the amount of DNA variation between 
populations taking into account the effect of the DNA polymorphism. KAlkS is the ratio of 
non synonymous polymorphic divergence to synonymous polymorphic divergence 
between two populations. Here a population is defined as a set of sequences from the 
same species or phylogenetic lineage. 
The divergence ratios, kAlkS, are generally very close between different species in each 
cluster tested (Table 5.3a, 5.3b and 5.3c). In Table 5.3a, the value of kAikS between the 
MTB complex and beta-proteobacterial species only differs slightly (0.38846 and 
0.38577, respectively). This seems to reject the previous hypothesis that the beta-
proteobacteria gene copy might be losing functionality. When the same phylogenetic 
lineage species are compared the difference is higher (0.597) than the divergence 
between different species of beta-proteobacteria (Table 5.3a). This suggests that 
para logs from the same species are more divergent compared to orthologs from different 
species, which is expected. 
However, the number of net sUbstitutions per site (DA values) indicates that the beta-
proteobacterial lineage and MTB complex copies of the gene have the longest 
divergence time, and there is an almost equal divergence time within proteobacterial 
lineage. This means that the distance between the MTB complex and beta-
proteobacterial lineage copy of the gene is greater than the distance between the 
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Table S.3a: Nucleotide divergence between species of MTB complex and Beta-
proteobacterial genes. 
Type of site 




























Number of net 
substitution 




Table S.3b: Divergence of the high-GC and M. tuberculosis complex genes. 
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substitution 
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Table 5.3c: Divergence of the MTB complex genes. 
Type of site 
MYCTU vs MYCBO 
Synonymous 
Nonsynonymous 
MYCTU vs MYCLE 
Synonymous 
Nonsynonymous 
MYCTU vs MYCPA 
Synonymous 
Nonsynonymous 
MYCBO vs MYCLE 
Synonymous 
Nonsynonymous 
MYCBO vs MYCPA 
Synonymous 
Nonsynonymous 
































Number of net 
substitutions 
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The divergence result allows an assumption to be made about when the duplication 
event occurred that created more than one copy of the gene in the beta-proteobacterial 
lineage. The assumption is that each lineage obtained a single copy of this gene from 
their ancestral gene and duplications occurred there after in beta-proteobacterial lineage 
copy of the gene. 
5.4.4 Neutrality test 
We conducted the McDonald and Kreitman [1991] test to investigate the hypothesis that 
all mutations are selectively neutral within and between the phylogenetic lineages within 
the same cluster [Kimura, 1983]. From the result in Table 5.4, we observed the ratio of 
non-synonymous fixed substitutions to synonymous fixed substitutions between lineages 
to be greater than the ratio of non-synonymous to synonymous polymorph isms within a 
lineage in all the clusters tested. Our results suggest that all mutations are not selectively 
neutral within and between the phylogenetic lineages within same cluster. Under the 
neutrality test as proposed by McDonald and Kreitman [1991], the ratio of non-
synonymous fixed substitutions to synonymous fixed substitutions, or differences 
between phylogenetic lineages should be equal to the ratio of non-synonymous to 
synonymous polymorph isms within a phylogenetic lineage. 
The results obtained above reject the neutral hypothesis tested and further confirm our 
observation in diversity (dN/dS) and divergence (kNkS) results that there is an 
evolutionary constraint on non-synonymous mutations to maintain the functionality within 
members of the same cluster. 
5.4.5 Phylogenetic trees 
Generating phylogenetic trees for pairs of sequences follows the principles that the 
extent of sequence differences is proportional to the length of the autonomous 
sequence. The results of estimated evolutionary distance and bootstrap neighbour-
joining evolutionary distance trees of genes members of the three clusters tested are 
shown in Figures 5.4, 5.5 and 5.6. The trees show that the distance between orthologs 
from different species within the same cluster are shorter than the distance between 
paralogs from the same species. Interestingly homologs (paralogs and orthologs) from 
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Table 5.4: Phylogenetic lineage neutrality test 




Fixed differences ratio 





















For example, Figure 5.4 reveals the relationship between the bi-functional gamma-
glutamyltransferase (GGT A) protein from 3 beta-proteobacteria species and 4 members 
of MTB complex organisms. Gene members from the beta-proteobacteria lineage are 
shown in BLUE and MTB Complex in RED. In the tree, MTB complex genes cluster 
together and their homologs from beta-proteobacteria also cluster together separately. 
However, paralogous genes from within species (BORPA and PORPE) are more 
phylogenetically distant from each other than the orthologs from these two species, 
which is to be expected. 
Generally the trees followed phylogenetic profiles of the gene members of the proteins 
rather than the species phylogeny. This is further confirmed by Figure 5.6 which shows 
the relationships between duplicated virulence factor mce proteins of the MTB complex. 
This tree also reveals that para logs from the same species are more distant to each 
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5.5 Conclusions 
Comparative evolutionary analysis studies are routinely employed for phylogeny studies. 
However, it has been shown (in this chapter) that it can also be utilized for identification 
of unique proteins at different levels between different organisms. A detailed 
investigation of functional or structural equivalence among homologous proteins from 
different organisms can also be revealed by evolutionary analysis. 
The evolutionary analysis results of different clusters confirmed that protein members 
from the same cluster are evolutionary related to each other and there is evidence of 
purifying selection against non-synonymous mutations and substitutions to maintain the 
same function or structure among the members of same cluster created by the 











General Conclusions and Future Work 
Simplicity is the final achievement. After one has played a vast quantity of notes 
and more notes, it is simplicity that emerges as the crowning reward of art. 
- Frederic Chopin 
The study of genome offers high prospects towards a better understanding of bacteria in 
general. Whole genome comparative genomic analysis of microbial pathogens and their 
associated disease processes has facilitated identification of new and better drugs and 
therapeutic targets. There is still the urgent need for functional annotation for most of the 
recently sequenced proteins and those pathogen proteins that are formerly annotated as 
unknown or hypothetical proteins. This will enable researchers to apply these data to 
understand what distinguishes pathogenic from non-pathogenic species and develop a 
faster and more effective drugs target for known pathogens and/or their proteins. 
In this work, we have produced a microbial phylogenetic profile for 84 genomes including 56 
pathogens and 28 non pathogens. We identified and started characterizing a set of genes 
from M. tuberculosis that were unique to pathogens or MTB complex organisms, and thus 
might be involved in the virulence and pathogenesis of these pathogens. 
The set of predicted proteins included many surface or secreted proteins, as well as some 
that are known to be involved in functions related to pathogenesis. The set also included a 
large number of hypothetical proteins that may be of interest for further study. 
We predicted potential functions for some of these proteins that were previously unknown or 
annotated as hypothetical proteins. 
We further perform evolutionary analysis to investigate some predicted virulence gene 
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purifying selection against non-synonymous polymorph isms and short evolutionary distance 
among related sequences from different pathogens. 
This evidence suggested that the same function or structure are likely to be maintained 
among members of the tested clusters, and allow us to further refine and to broaden 
annotation of protein functions in assisting drug development. 
However, to further confirm the predicted functions for all predicted virulence genes, more 
research efforts are needed to check whether they are also involved in similar pathways 
and whether they share similar expression profiles. In particular, among other things, future 
work should: 
• Investigate the potential role of these genes in virulence by understanding the stage and 
level of their expressions and identification of co-expressed genes. 
• Perform in silico comparative analysis with various host genomes to understand and 
gain insights into the mechanisms surrounding virulence of these pathogens, with 
emphasis on how they adapt to and evade the host immune response and how they 
interact with host genes. This can be achieved using functional information and 
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Table A-1a Contd. 
Organisms Cluster Number 
Code 
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Table A 1 b: The result of known virulence bacterial genes 1.0S 
Cluster Total Protein 




















Number of Present Virulence Virulence Total Protein in Number of 
AVE P Pathogens In TB? TB? in others? non pathogens AVE N non pathogens Total genomes TP in cluster 
19.9464 54 Y yin mtb yin SALTY* 959 34.25 26 80 2076 
11.0179 47 y yin SALTY* 506 18.071 25 72 1123 
4.839286 42 Y yin Vibch* 209 7.4643 22 64 480 
2.28571 55 Y yin LlSMO* 67 2.3929 25 80 195 
1.35714 53 Y yin LlSMO* 46 1.6429 28 81 122 
1.28571 51 Y yin SHIFL 39 1.3929 27 78 111 
1.30357 39 n yin STRR6 29 1.0357 19 58 102 
0.91071 51 Y yin PASMU 27 0.9643 27 78 78 
0.60714 21 Y yin BACAN 27 0.9643 15 37 61 
0.60714 29 y yin PSEAE 16 0.5714 14 43 50 
0.42857 22 Y yin ENTFA 11 0.3929 11 34 35 
4.83929 42 Y yin VBCH* 209 7.4643 22 64 480 
0.55357 6 n yin YERPS 0.0357 7 32 
0.07143 3 n yin BORPE 7 0.25 6 9 11 
0.07143 3 n yin EC057 2 0.0714 2 5 6 
0.07143 3 n yin EC057 2 0.0714 2 5 6 
0.03571 2 n yin BACAN 2 0.0714 2 4 4 
0.03571 2 n yin BACAN 2 0.0714 2 4 4 
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Table A1c: The result of known virulence bacterial genes 1.0S 
Cluster No Description line INTERPRO 
14 A TP-dependent_ Clp _protease _proteolytic_subunit_ (EC _ 3.4.21.92L(Endopeptidase_ Clp) IPR001907 
29 RNA polymerase sigma factor rpoD (Sigma-42) IPR011991 IPR007624 IPR007627 IPR007630 IPROO0943 PR012760 
131 Chaperone_clpB IPR003959 IPR004176 IPR001270 IPR003593 
341 Aldehyde_dehydrogenase_{EC_1.2.1.3) IPR002086 IPR012303 P23240 
Potassium-trans porting_ ATPase_B _chain _(EC _ 3.6.3.12L(ATP _phosphohydrolase _potassium-transporting_ IPR008250 IPR005834 IPR001757 IPR006391 
366 B_chainL(Potassium_binding_and_translocating_subunit_B 
522 ATP _synthase_gamma_chain_{EC_3.6.3.14L(ATP _synthaseJ1_sector_gamma_subunit IPROO0131 
1052 Zinc-binding_lipoprotein_adcAJ)recursor IPR006127 IPR006128 IPR006129 
2470 Phosphomannomutase/phosphoglucomutase_{EC_5.4.2.8L(EC_5.4.2.2L(PMM_I_PGM) IPR005845 IPR005841 IPR005843 IPR005846 IPR005844 
4241 Virulence_factors_putativeJ)ositive_transcription_regulator_bvgA IPR011991 IPR001789 IPROO0792 IPR011006 
5166 Transcriptional_regulatoryJ)rotein_basRlpmrA IPR001789 IPR001867 IPR011006 
6264 Sensor _protein_basS/pmrB _(EC _2.7.3.-) IPR003661 IPR003660 IPR003594 IPR004358 IPROO5467 IPR009082 
8270 Capsule_biosynthesis_protein_capB IPR008337 
IPR008338 
10321 Capsule_biosynthesis yrotein _ capC 
10631 Cytotoxic_protein _ ccd B _(Protein _letB L(Protein _ G L(Lyn B) IPR002712 IPR011067 
10744 Protein_ccdA_{ProteinJetAL{Protein_HL(LynA) IPR009956 
11052 Probable_ton B-dependent_receptor _ bfrD J)recursor _(Virulence-associated _outer_membrane _protein_Vir -90) I PROO0531 IPR012910 IPR010105 
IPR001789 IPR001638 IPR003661 IPROOO014 IPR008207 IPR003594 
IPR004358 
16892 Virulence_sensorJ)rotein_bvgS_precursor_{EC_2.7.3.-) IPROO5467 IPROO0700 IPR001311 IPR009082 IPR011006 
30401 AttachmenUnvasionJocusJ)rotein_precursor IPROO0758 










































































17 7 10 
17 7 10 
17 7 10 
21 10 22 
6 4 2 
13 4 4 
15 2 2 
3 0 
3 0 
25 14 2 
36 20 1 
49 38 9 
50 38 10 
19 6 5 
18 6 6 
25 9 2 
25 10 2 
o 0 0 
o 0 0 
o 2 
13 4 1 
11 3 2 
21 8 2 
15 3 2 
21 7 
16 4 0 
2 0 0 
2 0 0 
2 0 0 
2 0 0 
46 27 8 
31 16 6 
4 3 
41 24 9 
41 25 6 
2 2 2 0 
2 2 2 0 
2 2 2 0 
2 2 0 
2 2 1 0 













o 0 0 
000 
3 2 3 





2 2 0 
220 
2 2 0 
220 
3 2 2 2 
7 2 
o 1 0 
323 
3 2 3 





5 3 0 
6 3 0 
4 0 
9 5 2 
46 28 5 3 
54 41 10 4 2 
2 66 47 10 3 
15 19 221 0 
4 2 3 2 2 1 
3 2 2 2 
31 19 19 3 
27 11 12 2 1 
40 24 19 5 2 0 
64 45 9 3 2 1 
3 3 0 o 
5 3 1 0 
24 14 16 2 2 
27 14 18 2 2 
9 0 1 2 
5 0 0 2 0 






















































































































































































































































































































































































































































































































































































































































































Table A-2a contd. 
Organisms 
Code 
APPENDIX A: TABLES 
Cluster Number 
































17 7 10 2 2 2 0 
17 7 10 2 2 2 0 
17 7 10 2 2 2 0 
21 10 22 2 2 
33 7 7 3 
15 6 8 2 2 
15 5 5 2 2 
92 19 19 4 5 4 





11 5 2 2 0 0 
49 22 422 
37 11 11 2 
43 13 13 2 2 
26 8 15 2 
9 5 3 
13 6 2 4 2 
10 4 0 3 2 
27 9 0 
67 52 19 6 2 2 
67 62 26 4 2 
o 0 0 0 
o 0 0 0 
44 28 9 2 
o 0 0 
12 12 2 
44 42 13 2 
92 62 15 3 2 2 
47 30 2 2 2 
59 41 3 2 
































































































































































































































































































































































Table A-2b: The result of Known virulence bacterial genes 0.5 S 
Cluster No. Description line 




144 A TP-dependent_ Clp _protease_proteolytic_subuniUEC _ 3.4.21.92L(Endopeptidase_ Clp) 
176 AcYLcarrieryrotein_(ACP) 
201 Zinc-bindingJipoprotein_adcAyrecursor 
435 ATP _synthase_gamma _chain_(EC_3.6.3.14 L(ATP _synthaseJ1_sector_gamma_subunit) 
675 Capsule_biosynthesisyrotein_capD 
814 Phosphomannomutase/phosphoglucomutase_{EC _ 5.4.2.8 L(EC _ 5.4.2.2L(PMM _I_PGM) 
Potassium-transporting_ATPase_B _chain_{EC _ 3.6.3.12L(Potassium-
1116 translocating_A TPase_B _chain L(ATP _phosphohydrolase yotassium-transporting_ B _chain) 
1236 
1237 Altachmen!JnvasionJocusyrotein _precursor 
Probable_ton B-dependent_receptor _ bfrD _precu rsor _(Virulence-
2985 associated_outer_membraneyrotein_Vir-90) 
InterPro 
IPR011991 IPR001789 IPR001867 IPR005829 
IPR003661 IPR003660 IPR003594 IPR004358 
IPR0020861PR012303 
IPR004176 IPR003959 IPR003593 IPR013093 
IPR001907 




IPROO58451PR005841 IPROO5843 IPROO5846 











Capsule_biosynthesis _protein_ capB 
Capsule_biosynthesis yrotein _ capC 
Protein_ccdA_{Protein_letAL(Protein_HL(LynA) 
Putative _ su rface-exposed _virulence yrotein _ bigA _precursor 
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Table A-3b: The result of Known virulence Mycobacterium tuberculosis genes 1.0 S 
Cluster Total Protein Number of Present inTB? Virulence TB? Virulence Total Protein in Number of Total genomes Total Protein 
Number in pathogen Pathogen others? non-pathogens non pathogens in Cluster 
29 57 49 Y Y mtb Yin ENTIFA 33 26 75 90 
341 22 21 Y Y mtb Yin VIBCH 15 12 34 37 
366 24 22 Y Y mtb Yin ENTIFA 11 11 34 35 
652 16 8 Y Ymtb 8 5 13 24 
1583 7 7 Y Ymtb 7 4 11 14 
2441 10 5 Y Y mtbc 0 0 5 10 
2613 6 6 Y Y mtb 4 4 10 10 
2818 9 5 Y Ymtbc 0 0 5 9 
2820 9 5 Y Ymtbc 0 0 5 9 
2822 9 3 Y Ymtbc 0 0 3 9 
2823 9 5 Y Ymtbc 0 0 5 9 
2931 9 5 Y Y mtbc 0 0 5 9 
3332 8 5 Y Y mtbc 0 0 5 8 
7120 5 5 Y Ymtbc 0 0 5 5 
8232 4 4 Y Ymtbc 0 0 4 4 
8234 4 4 Y Y mtbc 0 0 4 4 
8935 4 4 Y Y mtbc 0 0 5 5 
11724 3 3 Y Ymtbc 0 0 3 3 
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Table A-3c: The result of Known virulence Mycobacterium tuberculosis genes 1.0 S 
Cluster No. Description line InterPro 
29 RNA_polymerase_sigma_factor_rpoD_(Sigma-A) IPR011991 IPR007624 IPR007627 IPR007630 IPR000943 IPR012760 
341 Aldehyde_dehydrogenase _famiILprotein/Hypothetical_protein IPR002086 IPR012303 
366 Potassium-transporting_ ATPase _8 _ chain_(EC _ 3.6.3.12) IPR008250 IPR005834 IPR001757 IPR006391 
652 
DNA-binding_response_regulator IPossible 2 components system response transcriptional positive regulator 
PHOP IPR001789 IPR001867 IPR011991 IPR005829 IPR011006 
Mycobacterial persistence regulator MRPA P (2 components response transcriptional regiulatory protein (DNA-
1583 binding_response_regulator IPR001789 IPR001867 IPR005829 IPR011006 
2441 Virulence_factor/MCE-FAMILY _PROTEIN IPR003399 IPR005693 
2613 Cytotoxin--'haemolysin _homologue _(CYTOTOXIN IHAEMOL YSIN_ HOMOLOGU E _ TL YAUCytotoxin/hemolysin) IPR002942 IPR002877 IPR004538 
2818 Virulence _factor _ mce _family-protein IPR003399 IPR005693 
2820 IPR003399 IPR005693 
2822 Phospholipase_ C _1_precursoUEC _3.1.4.3 UMTP40_ antigen) IPR007312 IPR006311 
2823 Virulence_factor _mce _family ""'protein IPR003399 IPR008360 IPR005693 
2931 IPR003399 IPR005693 
3332 Virulence _factor _mce _family ""'protein IPR003399 IPR005693 
7120 Heparin-binding_hemagglutinin_(Adhesin) PR000897 
8232 Sulfatase family protein IPR000917 
8234 IPR003399 IPR005693 
8935 Exported_repetitive_protein.....precursoUCell_surface.....protein.....pirGUEXP53) IPR008165 
11724 Viruience_factor_mce_family""'protein IPR003399 IPR005693 
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Table A-4b: The result of Known virulence Mycobacterium tuberculosis genes 0.5 S 
Cluster No Description Line 
2 MYCOBACTERIAL _PERSISTENCE_REGULA TOR_MRPA_(TWO _COMPONENT _ RESPONSE_TRANSCRIPTIONAL _IPR001789 
REGULATORY _PROTEINUDNA-binding_response_regulator) 
IPR011991 
49 RNA_polymerase_sigma_factor_rpoD_(Sigma-A) IPROO0943 
887 Cytotoxin -"haemolysin _homologue _(CYTOTOXINIHAEMOL YSIN_HOMOLOGU E_ TL YAUCytotoxin!hemolysin) IPR002942 
1679 MCE-FAMIL Y _PROTEIN_MCE2D _(Virulence_factor_mce_famiILProtein) IPR003399 
1681 Virulence_factor _ mce _family ~rotein IPR003399 
1699 MCE-FAMIL Y _PROTEIN_MCE1 B_(Virulence_factor_mce_family_protein) IPR003399 
1748 Virulence_factor_mce_family~rotein_(MCE-FAMIL Y _PROTEIN_MCE4A) IPR003399 
1823 Virulence_factor_mce_family~rotein IPR003399 
1883 Phospholipase_ C _1_precursor _(EC _3.1.4.3 UMTP40 _antigen)! IPR007312 
POSSIBLE_MCE-FAMIL Y _LlPOPROTEIN_LPRM_(MCE-FAMIL Y _LlPOPROTEIN_MCE3EUVirulence_factor_ 
1905 mce_famiILProtein) IPR003399 
5060 Possible _ virulence-regulating_ 38 _ kDa ~rotein IPR012287 
5995 Exported_repetitive_protein_precursoUCell_surface_protein_pirGUEXP53) IPR008165 
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Table A-4c: The result of Known virulence Mycobacterium tuberculosis genes 0.5 S 
Cluster Total Protein Number Virulence Virulence Total Protein in Number of Total Protein 
Number in pathogens of pathogens Present inTB? In TB? in others? non pathogens non pathogens Total genomes in cluster 
2 1117 54 Y yin mtb yin salty* 959 26 80 2076 
49 124 54 Y yin mtb 95 27 81 219 
887 27 27 y yin mtb 19 19 46 46 
1679 20 5 y yin mtbc 2 2 7 22 
1681 20 5 Y yin mtbc 2 2 7 22 
1699 20 5 Y yin mtbc 2 2 7 22 
1748 19 5 y yin mtbc 2 2 7 21 
1823 18 5 Y yin mtbc 2 2 7 20 
1883 14 7 Y yin mtb 5 4 12 19 
1905 17 5 y yin mtbc 2 2 7 19 
5060 6 3 y yin mtbc 0 0 4 6 
5995 5 5 y yin mtbc 0 0 5 5 
6392 5 5 y yin mtbc 0 0 5 5 
Un
ive
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of 
Ca
pe
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wn
